TW200916444A - Pyrazole carboxylic acid derivative, method of producing same and fungicide - Google Patents

Pyrazole carboxylic acid derivative, method of producing same and fungicide Download PDF

Info

Publication number
TW200916444A
TW200916444A TW097129688A TW97129688A TW200916444A TW 200916444 A TW200916444 A TW 200916444A TW 097129688 A TW097129688 A TW 097129688A TW 97129688 A TW97129688 A TW 97129688A TW 200916444 A TW200916444 A TW 200916444A
Authority
TW
Taiwan
Prior art keywords
group
carbon
carbon atoms
substituted
atom
Prior art date
Application number
TW097129688A
Other languages
Chinese (zh)
Inventor
Yutaka Chiba
Toshiyuki Kouno
Chie Shibata
Naofumi Tomura
Tomohisa Akase
Shinichi Banba
Original Assignee
Mitsui Chemicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Chemicals Inc filed Critical Mitsui Chemicals Inc
Publication of TW200916444A publication Critical patent/TW200916444A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/561,2-Diazoles; Hydrogenated 1,2-diazoles
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/80Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N47/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
    • A01N47/08Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
    • A01N47/10Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof
    • A01N47/20N-Aryl derivatives thereof
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N47/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
    • A01N47/08Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
    • A01N47/10Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof
    • A01N47/24Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof containing the groups, or; Thio analogues thereof
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N47/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
    • A01N47/08Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
    • A01N47/28Ureas or thioureas containing the groups >N—CO—N< or >N—CS—N<
    • A01N47/30Derivatives containing the group >N—CO—N aryl or >N—CS—N—aryl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32Nitrogen atom
    • C07D473/34Nitrogen atom attached in position 6, e.g. adenine

Abstract

The present invention provides a fungicide which exhibits an agricultural disease control action and is harmless, or mostly harmless, to crops. The fungicide of the present invention contains a pyrazole carboxylic acid derivative represented by the following formula (1) as an active ingredient: In formula (1), R1 represents an alkyl group and the like, R2 and R3 each independently represent a hydrogen atom, a haloalkyl group and the like in which at least one of R2 and R3 is a haloalkyl group having 1 to 6 carbon atoms, A represents-OR4, -SR5, -NR6R7 or -NR8NR9R10 in which R4represents an alkyl group having 3 to 12 carbon atoms and the like, R5 represents an alkyl group having 1 to 12 carbon atoms and the like, R6 represents a hydrogen atom and the like, R7represents an alkyl group having 5 to 12 carbon atoms, and R8, R9 and R10 each represent an alkyl group having 1 to 12 carbon atoms and the like.

Description

200916444 六、發明說明: 【發明所屬之技術領域】 本發明侧於_之士錄義生物及純造方法,並關於 以5玄吡唑羧酸衍生物當做有效成分之殺菌劑。 、 【先前技術】 病為治ϊϊϊϊ培上所達成的任務甚大。尤其水稻稻熱 ίί 有各種殺菌劑進行研發並應用。已知某種如坐 睛生物具有㈣活性(如倾日本專利特開平9—i76i25號公 口也软’具有齒化烧基及氮原子具取代苯環之醯胺鍵之°比 平2%ϋ ί 3具有殺草活性及殺蟲活性(如參照日本專利特開 千2-53775號公報、特開平2—129171號公報)。 寸’ 再者由環丨兄問題專之觀點,希求以安全且低濃声能、Λ 有害病菌之。 h且低祕夠防治 【發明内容】 「發明欲解決之課題」 甘=專利特開平9一176125號公報記載之”比讀酸衍生构 =且《财更《殺: 特開平2-129171味者曰本專利特開平2一53775號公報及 解決課題之方法」 物,ίί 題而合成各種新穎之吡唑羧酸衍生 Ϊ 為告或極少為害之化合物,乃完成本發明。 =,為解決上述課題之具體方法如下述。 下列一般式⑴表示之吡唑羧酸衍生物。 200916444200916444 VI. Description of the Invention: [Technical Field to Be Invented by the Invention] The present invention is directed to a biological and pure method for the recording of sinus, and a bactericidal agent which is an active ingredient of a 5-quinoxazolecarboxylic acid derivative. [Prior Art] The task of treating the disease is very big. Especially rice rice heat ίί has a variety of fungicides for research and development and application. It is known that some kind of living organisms have (4) activity (such as the Japanese patent special opening 9-i76i25, the male mouth is also soft 'having a toothed alkyl group and a nitrogen atom with a substituted benzene ring, the ratio of the indole bond is 2%ϋ ί 3 has herbicidal activity and insecticidal activity (for example, refer to Japanese Patent Laid-Open No. Hei 2-53775, JP-A No. 2-129171). In addition, from the point of view of the question of the brother-in-law, it is safe and Low-concentration sound energy, Λ harmful bacteria. h and low secret enough to prevent and cure [invention content] "The subject to be solved by the invention" Gan = Patent Unexamined-Japanese-Patent No. 9-176125, "The ratio of reading acid derivative = and "Killing: Unexamined-Japanese-Patent No. 2-129171, and the method of solving the problem", and the synthesis of various novel pyrazolecarboxylic acid-derived compounds, or compounds which are rarely harmful, The present invention has been completed. = The specific method for solving the above problems is as follows. The pyrazolecarboxylic acid derivative represented by the following general formula (1).

一般式(1 ) [式中’ R1表示氫原子或碳原子數1〜6之烷基; R2及R3各自獨立’表示氫原子、碳原子數1〜6之燒基、石炭原 子數1〜6之鹵化烷基、碳原子數1〜6之烷氧基、噥原$數二6 之鹵化烷氧基、碳原子數1〜6之烷硫基、碳原子數丨〜6之鹵化 少元石瓜基、奴原子數1〜6之烧亞確酿基、碳原子數1〜6之_化烧 亞磺醯基、碳原子數1〜6之烷磺醯基、碳原子數丨〜6之_化烷 石頁驢基、_素原子、氰基或梢基。但r2及r3之至少—方户子 數1〜6之_化烧基。 A ' A 表示一OR4、一SR5、一 NR6R7 或一NR8NR9R10。 R表不$反原子數3〜12之烧基、碳原子數3〜6之環烧基、碳 原子數2〜6之烯基、碳原子數3〜6之環烯基、碳原子數2〜6之 炔基、可被取代之雜芳基取代之碳原子數丨〜6之烷基、 之芳基、或可被取代之雜芳基。 R表示石反原子數1〜12之烧基、碳原子數3〜6之環院基、碳 原子數2〜6之烯基、碳原子數3〜6之環烯基、碳原子數2〜6 炔基、可被取代之雜芳基取代之碳原子數Η之絲呵被 之芳基、或可被取代之雜芳基。 如R7表示碳原子數5〜12之烧基、碳原子數2〜6之烯基 原子數3〜6之_基、、碳原子數2〜6之炔基、被羧基取代 ,子數1〜6之烧基或被碳原子數丨〜6之烧氧絲取代之碳原 ^ 1〜6之綠時,R6表示氫原子、碳原子數丨〜12之烧基、1 ^數2〜6之烯基、碳原子數3〜6之環烯基、碳原子數卜6之块 ΐπΐί取ί ίί ί基,基姻幾基、芳氧幾基、炫續酿基、' 方石買醯基 '彡元私友基、或芳胺幾基。 200916444 、又,如R7表示碳原子數3〜6之環烷基、可被取 可被取代之料基時,卩6表示麵子數2〜6 二或 〜6之環稀基、碳原子數2〜6之块基、可被取丈3 代之雜芳基、縣、烧氧、芳氧縣、燒m取 烧胺幾基、或芳胺錄。 土外酿基、 R、R及Γ各自獨立,表示氫原子、碳原子數丨〜丨卩 ί:4ί 碳原子數2〜6之縣、碳原子數兀3:6 子絲、可被取代之雜絲取代之碳原 其、H、可被取代之芳基、可被取代之雜芳基、醯基、 厌土方氧羰基、烷磺醯基、芳磺醯基、烧胺羰基、或芳胺 叛基。但’9不含R8、R9及R1Q均為氫原子之情形。 及R亦可互相鍵結形成碳原子數2〜&amp;之雜環基。] 於上述&lt;:1&gt;記载之吡唑羧酸衍生物,其中,一般式(1) 之R表不碳原子數1〜6之函化烷基。 於上述&lt;2&gt;記載之吡唑羧酸衍生物,其中,一般式(1) f 原子數1〜6之烧基,R2為碳原子數1〜6之氟院基,R3 為氫原子。 七A =4&gt;^亡述&lt;3&gt;記載之吡唑羧酸衍生物,其中,一般式(1) 之 A 為一NRR 或—随nr9r10。 &lt;4&gt;^5-,吡唑綾酸衍生物之製造方法,係製造上述&lt;i&gt;〜 項記載之°比唾緩酸衍生物’包含將下列一般式(2)表示 °與下列—般式(3)表示之化合物進行反應之製程。General formula (1) [wherein R1 represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms; and R2 and R3 each independently represent a hydrogen atom, a carbon atom having 1 to 6 carbon atoms, and a carbon atom number of 1 to 6; a halogenated alkyl group, an alkoxy group having 1 to 6 carbon atoms, a halogenated alkoxy group having a valence of 2, 6 or less, an alkylthio group having 1 to 6 carbon atoms, and a halogenated olivine having a carbon number of 丨6 A sulfonyl group having 1 to 6 carbon atoms, a sulfinyl group having 1 to 6 carbon atoms, an alkanesulfonyl group having 1 to 6 carbon atoms, and a carbon number of 丨6. _ alkane fluorenyl, _ atom, cyano or a base. However, at least the number of r2 and r3 is 1-6. A ' A represents an OR4, an SR5, an NR6R7 or an NR8NR9R10. R represents a non-reactive atomic group of 3 to 12, a cycloalkyl group having 3 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, a cycloalkenyl group having 3 to 6 carbon atoms, and 2 carbon atoms. An alkynyl group of hexamethylene, an alkyl group having a carbon number of 丨~6 substituted with a heteroaryl group which may be substituted, an aryl group, or a heteroaryl group which may be substituted. R represents a group having a stone inverse number of 1 to 12, a ring group having 3 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, a cycloalkenyl group having 3 to 6 carbon atoms, and 2 to 6 carbon atoms. 6 an alkynyl group, a heteroaryl group which may be substituted by a heteroaryl group, or a heteroaryl group which may be substituted. For example, R7 represents a group having 5 to 12 carbon atoms, a group having 3 to 6 carbon atoms having 2 to 6 carbon atoms, an alkynyl group having 2 to 6 carbon atoms, and a carboxyl group substituted by a carboxyl group. When 6 is burned or replaced by a carbon atom with a carbon number of 丨~6, the carbon atom is 1~6 green, and R6 represents a hydrogen atom, a carbon atom of 丨~12, and 1^2~6 Alkenyl group, cycloalkenyl group having 3 to 6 carbon atoms, number of carbon atoms, 6 ΐ ΐ 取 ί 取 ί ί ί ί ί ί ί ί ί ί ί ί ί ί ί ί ί ί ί ί ί ί ί ί ί ί ί ί ί ί ί ί ί ί ί ί彡元私友基, or a arylamine group. 200916444 Further, when R7 represents a cycloalkyl group having 3 to 6 carbon atoms and a substituent which can be substituted, 卩6 represents a ring-like group having a face number of 2 to 6 or 2 or 6 carbon atoms. ~6 block base, can be taken from the third generation of heteroaryl, county, burning oxygen, aryl oxygen county, burning m to the amine group, or aromatic amine record. The extraterrestrial base, R, R and Γ are independent, indicating that the hydrogen atom, the number of carbon atoms 丨~丨卩ί:4ί, the number of carbon atoms 2~6, the number of carbon atoms 兀3:6, can be replaced A halogen-substituted carbon atom, H, an aryl group which may be substituted, a heteroaryl group which may be substituted, a fluorenyl group, a anaerobic oxycarbonyl group, an alkane sulfonyl group, an aryl sulfonyl group, an amine carbonyl group, or an aromatic amine Rebel. However, the case where '9 does not contain R8, R9 and R1Q is a hydrogen atom. And R may be bonded to each other to form a heterocyclic group having 2 to 4 carbon atoms. The pyrazolecarboxylic acid derivative described in the above &lt;:1&gt;, wherein R of the general formula (1) represents a functional alkyl group having 1 to 6 carbon atoms. The pyrazolecarboxylic acid derivative described in the above <2>, wherein the general formula (1) f is a group having 1 to 6 carbon atoms, R 2 is a fluorine-based group having 1 to 6 carbon atoms, and R 3 is a hydrogen atom. The pyrazolecarboxylic acid derivative described in the above formula (1), wherein A of the general formula (1) is an NRR or - with nr9r10. &lt;4&gt;^5-, a method for producing a pyrazole decanoic acid derivative, which is produced by the above-mentioned &lt;i&gt;~, the ratio of the salicylic acid derivative, which comprises the following general formula (2) and the following - The process in which the compound represented by the general formula (3) is subjected to a reaction.

•般式(2) [式中’V、R2及R3分別與一般式⑴之RHR3相同定義 200916444 一般式(3) [式中’A與—般式⑴之a相同定義。] &lt;6&gt; 一種吡唑鲮酸衍生物之製造方法,係製造上述&lt;1&gt;〜&lt; 4&gt;任一項記載之吼唑羧酸衍生物,包含將下列一般式(4)表示之化 合物與下列一般式(3)表示之化合物進行反應之製程。 R2• General formula (2) [wherein, 'V, R2, and R3 are the same as RHR3 of the general formula (1), respectively. 200916444 General formula (3) [wherein 'A is the same as the definition of a of the general formula (1). And a carbazolecarboxylic acid derivative according to any one of the above-mentioned <1> to <4>, which is represented by the following general formula (4), which is a method for producing a pyrazole acid derivative. A process in which a compound is reacted with a compound represented by the following general formula (3). R2

1 Ο —般式(4) A· 一般式(3) [式中,A與一般式(1)之A相同定義。] &lt;7&gt;—種殺菌劑,含有上述&lt;;1&gt;〜 缓酸衍生物之至少!種#做有效成分。 任—細載之如坐 「發日 上述&lt;7&gt;項記載之殺菌劑,為農園藝用殺菌劑。 依據本發明,能夠提供表現優異之植物 a 對水稻稻熱病表現優異防治作用,同時 二’尤其 或極少為害之咖坐羧酸衍生物。 才T於有用作物视任何為害 【實施方式】 以下洋細說明本發明。 7 200916444 本發明之吡唑羧酸衍生物,以下列一般式(1)表示 R2 R31 Ο General (4) A· General formula (3) [wherein, A is the same as A of general formula (1). ] &lt;7&gt; - a fungicide containing at least the above &lt;1&gt;~ slow acid derivative! Kind # do the active ingredients. Any of the above-mentioned bactericidal agents described in the above-mentioned &lt;7&gt;, is a bactericidal agent for agricultural and horticultural use. According to the present invention, it is possible to provide an excellent performance of the plant a for controlling rice rice fever, and at the same time 'In particular or very little harm, it is a carboxylic acid derivative. Only T is useful in any useful crop. [Embodiment] The present invention is described below. 7 200916444 The pyrazolecarboxylic acid derivative of the present invention is represented by the following general formula (1) ) indicates R2 R3

一般式(1 ) W这又ί i i中,R表示氫原子或碳原子數1〜6之烧基; R及R各自獨立’表示氫原子、碳原子數卜6之燒其 子數1二6之·貌基、碳原子數卜6之烧氧基、碳原,j 1鹵化烧,基、碳原子數丨〜6之燒硫基、碳原子數卜6之 其碳巧子數1〜6之烷亞磺醯基、碳原子數1〜6之齒化j 原子數1〜6之烧4醯基、碳原子數1〜6之鹵化^ 醯基、鹵素原子、氰基或石肖基。但R2及R3之至少-方為石户^ 數1〜6之齒化烷基。 万為反原子 基較ί本發明,由殺菌活性之觀點,R2以碳原子數1〜6之純燒 rA又之觀點,—般式⑴之1^為碳原子數1〜6之 二一 原子數1〜6之氟烧基,R3為氫原子更好。 乂 士 :又^ Γ) ’ Α 表示—〇R4、—SR5、—NR6R?、或—NRS_i〇。 基、碳原子數烯^ 基、碳原〜6之環燒 η . 、 烯基反原子數3〜6之環烯基、碳原子數?In the general formula (1) W and ί ii, R represents a hydrogen atom or a carbon atom having a carbon number of 1 to 6; R and R are each independently 'representing a hydrogen atom, a number of carbon atoms, and a number of calories. The appearance base, the number of carbon atoms, the alkoxy group of carbon 6, the carbonogen, the calcination of j 1 , the base, the number of carbon atoms 丨~6, the sulfur-burning group, the number of carbon atoms, the number of carbon atoms, 1 to 6 Alkylsulfinyl group, a toothed group having 1 to 6 carbon atoms, a halogenated group having 1 to 6 atomic number, a halogenated group having 1 to 6 carbon atoms, a halogen atom, a cyano group or a schloss group. However, at least the square of R2 and R3 is a dentate alkyl group of the number 1 to 6 of the stone. In the present invention, from the viewpoint of bactericidal activity, R2 is a purely calcined rA having a carbon number of 1 to 6, and the general formula (1) is a two-atom atom having 1 to 6 carbon atoms. The number of fluoroalkyl groups is 1 to 6, and R3 is more preferably a hydrogen atom.乂士:又^ Γ) ’ Α indicates —〇R4, —SR5, —NR6R?, or —NRS_i〇. a group, a carbon atom number, an alkyl group, a carbon atom of -6, a ring-burning η. , an alkenyl group having an alkyl group of 3 to 6 and a carbon number?

i取代之^Α可1取代之雜芳基取代之碳原子數1〜6之烧基、可 被取$之方基、或可被取代之雜芳基。 J ρί ϋ2之絲、碳原子數3〜6之魏基、碳 碳原子數3〜6之輯基、碳原+數2 之ί基、或可‘gig之碳原子數1〜6之烧基、可被取代 斤子數5〜12之燒基、碳原子數2〜6之烯基、碳 ’、 .、元土、或被碳原子數1〜6之烷氧羰基取代之碳原 200916444 子數1〜6之烷基時,R6表示氫原子、碳原子數丨〜丨卩 ^數2〜6之稀基、碳原子數3〜6之賴基、碳原子數U ,基、—可被料之雜芳基、酿基、⑥氧、芳氧幾基、尸石 基、芳磺醯基、烷胺羰基、或芳胺羰基。 兀κ _ ^示碳原子數3〜6之環烧基、可被取代之芳基、或 可被取代之㈣基時,p表示碳原子數2〜6之稀基 ^ 二6之環絲、碳原子數2〜6之炔基、可被取代之芳基]可被取 ίίΪΪ基,、ί纖、芳娜、烧磺醯基、芳磺醯基、 烷月女碳基、或芳胺羰基。 土 R、R及…各自獨立,表示氫原子、碳原子 碳原子數3〜6之環絲、碳原子數2〜6之烯基、碳6 子數2〜6之絲、可被取代之料絲代之破原 )ΐ^6之巧山1可被取f之芳基、可被取代之雜芳基、醯基、 ί Γί、基、烧,基、芳賴基、垸胺絲、或芳胺 板基。但,不含R8、RlQ均為氫原子之情形。 ^β及Γ亦可互相鍵結形成碳原子數2〜5之雜 戍-由殺菌活性之觀點,以—般式⑴之“—nr6r7 绩酸衍生物較好;且以一般式⑴之A為一 為碳原子數卜6之純絲之財駿衍生物更 卜βΪΪ其以:ί式⑴之八為,以―_ν,Ρ為破原子數 酸衍生物^。子數1〜6樣完基,R3錢射之咖鐘 佳取代基之組合’為上述一般式⑴中R1為甲基, 子數^12 氮原子’ A為,V,R6為氫原子,R?為碳原 =rm合;或ri為甲基,r2為三氟甲基,R3為氮 12之院基、仰取代之磺·,R7為綠子數5〜 太於明夕曰t戈之方基或可被取代之雜芳基之組合。 美,ίίΐίίΐ取代基之、组合,為上述—般式⑴中R1為甲 &quot;”、、甲基,R為虱原子,八為—_7,R6為氫原子,R7為 200916444 碳原子數5〜12之^之組合;或γ為甲基,r2 j氫原子,a為-_,r6為芳顧基,R7為可被 在本發明之吼錢酸衍生物,上述破原子數 甲基:乙基、丙基、丁基、戊基、己基等,上二π舉 之烧基可舉丁基、戊基、己基、庚基、辛基、壬義H丈3 12 烷基、十二烷基等,上述碳原子數二天土、十一 J 1;e . 基、十二烧基等,上述碳原子數5〜12之貌基可十说 庚基、辛基、壬基、癸基、十一烷基、十二烷基等。土 土 又,碳原子數1〜6之鹵化院基可舉三氟甲土基、 氟甲基、氣二氟甲基、溴二氟甲基、三氣甲基、三淳7鼠甲基:、-?基、五氟乙基、三氯乙基、三溴乙基、三氟丙基、全:厂 !〜6之氟烧基可舉三氟甲基、二氟f基、—氟二夂 齓乙基、五氟乙基、三氟丙基、全氟丙基等。 土 一 碳原子數1〜6之錄射Μ氧基、乙氧 g,巧碳=數!〜6之心诚氧基可舉三氟甲氧^基三二 〜6土之2乙氧基:全㈣氧基等,上述碳原子數1 〜6之鹵化烧硫基可舉三I甲硫基、三氟乙硫基、三匕^ 上,,,子數卜6之航魏基可舉曱亞顧基、乙亞 二、—士述故原子數丨〜6之齒化烧亞續酿基可舉三氣 ^ ^ =乙亞續醯基、三氣乙亞石細基等,上述碳 ^ ί ϊί可舉甲雜基、乙_基等,上述磁原子數之^ 舉三氟甲雜基、三氟乙梅、三氯乙碍3化 上述鹵素原子可舉氟、氯、溴、诚土等 述碳6乙=说:稀ί、丁稀基、戊稀基、己稀基等上 人原子數3〜6之_基可舉環_基、釘烯基、環戊^基十 10 200916444i substituted by a heteroaryl group substituted with a heteroaryl group substituted with a carbon atom having 1 to 6 carbon atoms, a square group which may be taken, or a heteroaryl group which may be substituted. a filament of J ρί ϋ2, a Wei group having a carbon number of 3 to 6, a radical having a carbon number of 3 to 6, a carbon atom + a number 2, or a carbon atom of 1 to 6 of 'gig a carbon atom which can be replaced by a calcining group of 5 to 12, an alkenyl group having 2 to 6 carbon atoms, a carbon ', a metabosic, or an alkoxycarbonyl group substituted with a carbon number of 1 to 6; In the case of an alkyl group having 1 to 6 carbon atoms, R6 represents a hydrogen atom, a rare carbon group having a carbon number of 丨~丨卩^2 to 6, a lysine having 3 to 6 carbon atoms, a number of carbon atoms U, a group, and the like. Heteroaryl, aryl, 6 oxo, aryloxy, skeletal, arylsulfonyl, alkylamine carbonyl, or arylamine carbonyl.兀κ _ ^ shows a cycloalkyl group having 3 to 6 carbon atoms, an aryl group which may be substituted, or a (tetra) group which may be substituted, and p represents a ring group of 2 to 6 carbon atoms; An alkynyl group having 2 to 6 carbon atoms, an aryl group which may be substituted] may be taken as an ί, ί, 芳, sulfonyl, arylsulfonyl, alkane, or arylamine carbonyl group. . The soils R, R and ... are each independently, and represent a hydrogen atom, a ring carbon having 3 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, a filament having 2 to 6 carbon atoms, and a material which can be substituted. The genus of 丝^6 巧 山 可 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 Aromatic amine plate base. However, the case where R8 and RlQ are not hydrogen atoms is not included. ^β and Γ can also be bonded to each other to form a heterodole having a carbon number of 2 to 5 - from the viewpoint of bactericidal activity, the "-nr6r7 acid derivative of the general formula (1) is preferred; and the general formula (1) A is One is the carbon atom number b 6 pure silk of the wealth of the derivative of the more ΪΪ β ΪΪ 以 ί ί ί ί ί ί ί ί ί ί ί ί ί ί ί ί ί ί ί ί ί ί ί ί ί ί ί ί ί ί ί ί ― ― ― ― ― ― ― , R3 money shot of the combination of the base of the calorie is 'in the general formula (1), R1 is a methyl group, the number of ^12 nitrogen atom 'A is, V, R6 is a hydrogen atom, R? is a carbon source = rm combination; Or ri is methyl, r2 is trifluoromethyl, R3 is the base of nitrogen 12, sulfonate is replaced by R, and R7 is the number of greens 5~ too square or can be replaced The combination of aryl groups. The combination of aryl, ίίΐ ίί ΐ , , 为 — — — — — — R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R a combination of a carbon number of 5 to 12; or γ is a methyl group, a r 2 j hydrogen atom, a is -_, r6 is a aryl group, and R7 is a derivative of the ruthenium acid which can be used in the present invention. Number of methyl: ethyl, propyl, butyl , pentyl, hexyl, etc., the upper two π exemplified by butyl, pentyl, hexyl, heptyl, octyl, oxime H zhang 3 12 alkyl, dodecyl, etc., the above two carbon atoms Tiantu, eleven J 1; e. base, dodecapine, etc., the above-mentioned carbon atom number 5~12 appearance base can be said to be heptyl, octyl, decyl, decyl, undecyl, twelve Alkyl and the like. In addition, the soil and the halogenated compound with a carbon number of 1 to 6 may be a trifluoromethane group, a fluoromethyl group, a gas difluoromethyl group, a bromodifluoromethyl group, a tris-methyl group, a triterpene 7-methyl group: ,-? base, pentafluoroethyl, trichloroethyl, tribromoethyl, trifluoropropyl, all: factory! The fluoroalkyl group of ~6 may, for example, be a trifluoromethyl group, a difluorof group, a fluorodioxime ethyl group, a pentafluoroethyl group, a trifluoropropyl group or a perfluoropropyl group. Soil A carbon number of 1 to 6 recorded methoxy, ethoxy g, Q carbon = number! The ethoxy group of ~6 is exemplified by a trifluoromethoxy group, a bis(ethylene) oxyethylene group, a hexyloxy group, a hexyloxy group, a hexyloxy group, a hexyloxy group, a sulfonyl group having 1 to 6 carbon atoms, and a trithiol group. Base, trifluoroethylthio, triterpenoid, on,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, The base can be lifted by three gas ^ ^ = Ethylene continued sulfhydryl, three gas and ethyl sulphide fine base, etc., the above carbon ^ ί ϊ ί can be a heteropoly group, a B group, etc., the above number of magnetic atoms of the trifluoromethane The group, the trifluoroethylene, the trichloroethane, the halogen atom, the fluorine atom, the fluorine, the chlorine, the bromine, the earth, etc., the carbon 6 B = said: thin, butadiyl, pentyl, hexyl, etc. The number of atoms of human 3~6 can be raised as ring_base, nail alkenyl, cyclopentyl group 10 10 200916444

ΪΓΐίι上述碳原子數2〜6之块基可舉乙絲、丙块基、丁 炔基、戊炔基、己炔基等。 土 J 其、基可if基、萘基等’上述雜芳基可舉*定基、♦定 ί埋口金土甘比啡土、噻吩基、呋喃基、吡唑基、咪唑基、噻唑 ^、嗟峻基、口寄唾基、異今坐基、口引嗓基、喧琳基、里啥似、 本开咬喃基、苯㈣吩基、科·基、^ 。坐基、苯并嗟唾基、苯并異嗟唾基等。U錄本开味 上述碳料5 2〜5之轉射舉味储、硫代魏基 呒基(aZiridlnyl)、吡咯啶基、哌啶基、哌畊基、吡咯基等。 與田i ’上Ϊ可被取代之絲及可餘代之雜絲之取代基,可 丄二成蓋T基等烧基;苯基等芳基;環丙基、環丁 基、%戍基及壤己基麵烧基;三亂甲基、二氟甲基、溴二說甲 基及二乱乙基«素取代烧基;甲氧基、乙氧基、丙氧基及丁氧 丄i氟甲氧基、二氟甲氧基及三氟乙氧細素取代 烧乳基,曱瓜基、乙硫基、丙硫基、丁硫基等烧硫基;三氣甲硫 基、二敦甲硫基及三氟乙絲料素取代炫硫基;甲亞顧基、 乙亞石黃醯基、丙亞石黃醯基及丁亞石細基等烧亞石練基;三氣甲亞 石黃醯基l二氟甲亞顧基及三氟乙亞枷基等較取代炫亞補 基;曱磺驢基、乙磺酿基、丙續醯基及丁續醯基等縣醯基;三 氟甲石黃醯基、二氟甲績醯基及三氟乙伽基等齒素取代烧石黃醯 基,乙醯胺基、笨甲醢胺基等醯胺基;磺醯胺基、丁磺醯胺基等 炫石黃酸胺基,二氟甲續g!絲、二醯胺基及三氟乙石黃酿胺 基專鹵素取代纟元胺基;氟、氯、溴.、碳之函素原子;氰基; 硝基;乙醯基、苯甲醯基等醯基。 土’ 上述醯基可舉乙醯基等之烷羰基,苯醯基等之芳羰基及可被 取代之σ比唑羰基等之雜芳羰基等;上述烧氧羰基可舉甲氧羰基、 丙氧幾基等,上述芳氧幾基可舉苯氧幾基等。 上述烷磺醯基可舉甲磺醯基、丙磺醯基等;上述芳磺醯基可 舉苯磺醯基,上述烧胺幾基可舉曱胺幾基、丙胺幾基等;上述芳 胺羰基可舉苯胺羰基等。 ’ 200916444 &lt;吡唑羧酸衍生物之製造方法(A) &gt; 本發明之吼嗤羧酸衍生物之製造方法(A) ’包含使下列一般式 (2)表示之化合物與下列一般式(3)表示之化合物進行反應之製 程。亦即’本發明之11比。坐叛酸衍生物可依下列反應式(1)表示之反 應進行製造。 反應式⑴Further, the above-mentioned block having 2 to 6 carbon atoms may, for example, be an ethyl group, a propyl group, a butynyl group, a pentynyl group or a hexynyl group. The above heteroaryl group can be defined as a base, ♦ 固 固 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金 金Junji, sputum, sputum, sputum, sputum, sputum, scorpion, scorpion, sputum, benzene (tetra) phenyl, ke, ke. Sitrate, benzopyrene, benzoisoindolyl, and the like. U-recording of the above-mentioned carbon material 5 2~5 of the transfer of odor storage, thio-wei group, aZiridlnyl, pyrrolidinyl, piperidinyl, piperylene, pyrrolyl and the like. And the substituents of the silk which can be replaced by the Ϊi' Ϊ 及 及 及 及 及 及 及 , , , , , , , , , , 取代 取代 取代 取代 取代 取代 取代 ' ' ' ' ' ' ' ' ' ' ' ' ' And hexyl ketone base; three chaotic methyl, difluoromethyl, bromine, methyl and di-ethyl ester substituted calcination; methoxy, ethoxy, propoxy and butoxy oxime The methoxy group, the difluoromethoxy group and the trifluoroethoxy ethoxylate are substituted for the calcined base, the thiol group, the ethylthio group, the propylthio group, the butylthio group and the like; the trimethylthio group and the second group Substituting thiol and trifluoroethyl silk to replace sulphur-thiol; sulphate, sulphate, sulphate, sulphite, and stellite base; tri-gas sulphate Guji and trifluoroethyl sulfhydryl groups are more suitable for the replacement of daunxine; sulfonyl sulfonyl, ethyl sulfonate, propyl sulfhydryl and butyl sulfhydryl; trifluoromethane xanthine, difluoromethyl A sulphate group such as a fluorenyl group and a trifluoroethylene group, such as a sulfonium fluorenyl group, an acetoguanamine group, an amidoxime group; Difluoromethyl continued g! silk, diamylamine and three B stuffed stone yellow spot amine group substituted with a halogen group element Si; fluorine, chlorine, bromine, carbon atoms of the functional element;. Cyano; nitro; acetyl group, benzoyl and the like acyl groups. The above sulfhydryl group may be an alkylcarbonyl group such as an ethenyl group, an aromatic carbonyl group such as a benzoquinone group or a heteroarylcarbonyl group such as a succinylcarbonyl group which may be substituted; and the above-mentioned alkoxycarbonyl group may be a methoxycarbonyl group or a propoxy group. The above aryloxy group may be a phenoxy group or the like. The alkanesulfonyl group may be a methylsulfonyl group or a propyl sulfonyl group; the above arylsulfonyl group may be a benzenesulfonyl group, and the above amine group may be an amidino group, a propylamine group or the like; The carbonyl group may, for example, be an aniline carbonyl group or the like. '200916444 &lt;Production Method (A) of Pyrazole Carboxylic Acid Derivatives> The method for producing an indolecarboxylic acid derivative of the present invention (A) 'comprises the compound represented by the following general formula (2) with the following general formula ( 3) A process in which the indicated compound is subjected to a reaction. That is, the 11 ratio of the present invention. The taustic acid derivative can be produced by the reaction represented by the following reaction formula (1). Reaction formula (1)

反應式(1)中,R1、R2 、R及八分別與一般式(1)中之R1 R3及A相同定義。 在反應式(1),將一般式(2)表示之吡唑羧酸與一般式(3)表示 之化合物,在無溶劑或溶劑中進行縮合反應,能夠製造一 表示之吡唑羧酸衍生物。 號公:羧酸如可依日本專利特開平2 — ⑶表x示nr8nr9r1&gt; ’缺用一般式 無機酸或有機可使用之鹽之酸類並無特別限制, 心反應式⑴,亦可使職合劑進行反應。可使用之# 鹽酸鹽、氣化-2 -氣—l 3 _二甲基'咪::胺㈣碳化二亞胺· 使用縮合劑時,縮合劑使用量為一 1〜2莫耳當量,並以H. 2莫耳^量^⑵表不之啊驗之 在反應式(D使用溶劑時,溶劑並I料Χ|丨卩卜 機溶劑均可。具體可舉例如水;甲醇、劑或有 于叼醉丁醇等醇類; 12 200916444 二氯曱烷、氯仿等ii化烴類;苯、曱苯、二曱苯等芳香族烴類. 己烷、庚烷等脂肪族烴類;二曱基曱醯胺(DMF)、二曱基乙^月—’ (DMA)、一曱亞石風(DMS0)、1,3 -二曱基-2_ σ米峻α定酮(贿)、1 _ 曱基-2 -吼咯啶嗣(贈)等非質子性極性溶劑;二乙_、異丙喊、 1,2-二曱氧基乙烷(dme)'四氫呋喃(THF)、二口号烷等醚類:r睥、 丙腈等腈類等。 、’腸、 在反應式(1),一般式(2)表示之。比嗤叛酸之使用量為—般式 (3)表示之化合物之1〜2莫耳當量,並以i〜L 2莫耳當量較^。 又,上述反應式(1)之反應溫度與反應時間,可在廣範圍&quot;内改 變。一般而言,反應溫度為一2(TC〜2〇〇。(:,並以^(:〜丨⑽它較好。 又’反應時間為〇· 01〜5〇小時,並以〇. 1〜15小時較好。 &lt;吡唑羧酸衍生物之製造方法(B) &gt; 本^發明之吡唑羧酸衍生物之製造方法(B) ’包含使下列—般式 表示之化合物與下列一般式(3)表示之化合物進行反應之製^ 程。亦即,本發明之吡唑羧酸衍生物可依下列反應式(2)表示1 應進行製造。 反應式(2)In the reaction formula (1), R1, R2, R and VIII are respectively defined in the same manner as R1 R3 and A in the general formula (1). In the reaction formula (1), a pyrazolecarboxylic acid derivative represented by the general formula (2) and a compound represented by the general formula (3) are subjected to a condensation reaction in a solventless or solvent to produce a pyrazolecarboxylic acid derivative represented by the formula (1). . No.: carboxylic acid can be used according to Japanese Patent Laid-Open No. 2 - (3) Table x shows nr8nr9r1&gt; 'The use of a general inorganic acid or an organically usable salt is not particularly limited, and the cardiac reaction formula (1) can also be used as a service agent. Carry out the reaction. Can be used #HCl, gasification-2 - gas - l 3 _ dimethyl 'mi:: amine (tetra) carbodiimide · When using a condensing agent, the amount of condensing agent used is 1 to 2 molar equivalents, And H. 2 Moer^^(2) is not shown in the reaction formula (D when solvent is used, solvent and I material Χ | 机 machine solvent can be. Specific examples are water; methanol, agent or An alcohol such as butyl alcohol; 12 200916444 Dihydrosilane, chloroform, etc.; aromatic hydrocarbons such as benzene, toluene, and diphenyl; aliphatic hydrocarbons such as hexane and heptane; Baseline amine (DMF), dimercapto-ethyl-month-' (DMA), sputum stone (DMS0), 1,3 -dimercapto-2_ σ mugh alpha ketone (bribe), 1 _ Aprotic polar solvent such as mercapto-2-pyrrolidine (gift); diethyl _, isopropyl sulfonate, 1,2-dimethoxy ethane (dme) 'tetrahydrofuran (THF), di-n-halo, etc. Ethers: nitriles such as r睥 and propionitrile, etc., 'intestines, expressed in the reaction formula (1), general formula (2). The amount of the compound used in the formula (3) is 1 to 2 molar equivalents, and i to L 2 molar equivalents ^. Further, the above reaction formula (1) The reaction temperature and the reaction time can be changed in a wide range. In general, the reaction temperature is 1 (TC~2〇〇. (:, and ^(:~丨(10) is better. Further 'reaction time 〇· 01~5〇小时, and preferably 〇. 1~15 hours. &lt;Production method of pyrazolecarboxylic acid derivative (B) &gt; The method for producing pyrazolecarboxylic acid derivative of the invention B) 'containing a process for reacting a compound represented by the following formula with a compound represented by the following general formula (3). That is, the pyrazolecarboxylic acid derivative of the present invention can be represented by the following reaction formula (2) 1 should be manufactured. Reaction formula (2)

3反應式(2)中,R1、R2、R3及A分別與一般式(1)中之R1、R2、 R及A相同定義,γ為脫去基。 以Y表示之脫去基,可將通常使用於縮合反應之脫去基使用 於本發明。具體可舉例如以氣原子代表之鹵素原子,以曱氧基及 -乙氧基代表之烷氧基,以苯氧基代表之芳氧基,以乙醯氧基代表 _ 氧基,以甲氧羰氧基代表之烷氧羰氧基,以苯羰氧基代表之 芳羰氧基,N -羥基琥珀醯亞胺,1 _羥基苯并三唑及咪唑基等。 13 200916444 -示之 在反應式(2) ’使一般式(4)表示之化合物與一 化合物,在無溶劑或溶劑中進行反應,能夠^ —=士(3)表 吡唑羧酸衍生物。 奴式(丨)表示之 以反應式(2)表示之反應,可在鹼類存在下進疒 上述鹼類並無特別限制,無機鹼類或有ϋ 化解氫氧化驗土金屬類’氫化鋼、氫化钾氫氧 ,、乙醇鈉等驗金屬醇鹽類,氧化納等驗:,,甲 鉀、碳酸納等碳酸鹽類,構酸三钟、碟酸三納蜀類’碳酸 酸氫二納等磷酸鹽類,醋酸納、醋酸钟等醋酸 卸、石粦 二.胺基°比°定、三乙胺、二氮雜^雙環H—彳In the reaction formula (2), R1, R2, R3 and A are the same as defined in the general formula (1), R1, R2, R and A, respectively, and γ is a leaving group. The leaving group represented by Y can be used in the present invention by a de-radical which is usually used in a condensation reaction. Specific examples thereof include a halogen atom represented by a gas atom, an alkoxy group represented by a decyloxy group and an ethoxy group, an aryloxy group represented by a phenoxy group, an ethoxy group represented by an ethoxy group, and a methoxy group. The carbonyloxy group represents an alkoxycarbonyloxy group, an arylcarbonyloxy group represented by a phenylcarbonyloxy group, an N-hydroxysuccinimide, a 1-hydroxybenzotriazole, an imidazolyl group and the like. 13 200916444 - It is shown that the compound represented by the general formula (4) and a compound are reacted in a solvent-free or solvent in the reaction formula (2) to give a pyrazolecarboxylic acid derivative. The slave type (丨) indicates that the reaction represented by the reaction formula (2) can be carried out in the presence of a base, and the above-mentioned alkali is not particularly limited. The inorganic base or the hydrazine-decomposing metal test metal-hydrogenated steel, Potassium hydride, sodium ethoxide, etc., metal oxide alkoxides, sodium oxide, etc.:, potassium carbonate, sodium carbonate and other carbonates, acid acid three clocks, dish acid trisodium quinones, hydrogen carbonate dihalon, etc. Phosphate, acetic acid sodium, acetic acid clock and other acetic acid unloading, Dendrobium diamide. Amino group ratio, triethylamine, diazabicyclo-2, H ring

Cdiaza-bicyclo-undecene)等有機驗類等。 埽 在反應式(2)使用鹼類時,其使用量並益特 有機鹼類時可當做反應式(2)之溶劑使用。…、义j。尤其使用 又上述反應式(2)之反應溫度與反應時間, 變。一般而言,反應溫度為-赃〜·。c,並則改 又,反應時間為〇. 〇1〜50小時,並以〇.卜15小時較好。乂 上述-般式⑷表示之化合物,可依常法制上述 =之財羧酸製造。例如,使上述—般式⑵表示之㈣ ϊ^ί、,氣、光氣、經基氯化鱗、三氣化碟、五氣化磷:、 溴、三溴化磷、二乙胺基三氟化硫、】, 咪唑等進行反應而製造。 文 又,一般式⑷表示之化合物,可依常法使一般式⑵表示之 ^竣酸與甲醇、乙醇等醇類於無觸媒或觸媒存在下進行反應而 &lt;殺菌劑&gt; 14 200916444 • 卞赉月又菌劑,含有上述一般式(1)表示之^比峻羧酸衍生物 ^至少1種當做有效成分。依此,能齡現健之植物病害防治 作用。 ^本發明之殺菌劑之用途並無特別限制,如可當做防腐、防黴 =等之工業用殺菌劑,農園藝用殺菌劑’醫療用、消毒用殺菌劑 等。由於本發明之殺菌劑表現植物病害防治作用,故尤以當做農 園藝用殺菌劑較好。 +本發明之殺菌劑能夠使用於由屬於印菌綱(Oomycetes)、子囊 菌綱(Ascomycetes)、不完全菌綱(j)euteromycetes)、擔子菌綱 (Basidiomycetes)、根瘤病菌綱(piasm〇di〇ph〇romyCetes)及其他 病原菌引起之蔬菜、果樹、水稻、穀類、花卉、草皮等各種各樣 之植物病害。 其次,列舉能夠使用本發明之殺菌劑之具體病害名稱(病原菌 名)當做非限定例。 水稻之稻熱病(Magnaporthe grisea(Pyricularia oryzae))、胡麻葉枯病(Cochliobolus miyabeanus)、紋枯病 (Rhizoctonia solani)、苗徒長病(Gibberella fujikuroi)、腐 霉屬iKPythium)引起之缺苗立枯病(Pythium graminicola等); 麥類之白粉病(Erysiphe gramiis f.sp. hordei ; f.sp. triici)、斑葉病(Pyrenophora graminea)、網斑病 Pyrenophora teres(網斑病)、赤黴病(Gibberella zeae)、銹病 (Puccinia striiformis ; P. graminis i P. recondite i P. hordei)、雪腐病(Typhula sp.&amp; Micronectriella nivalis)、 裸黑穗病(Ustilago tritici &amp; U. nuda)、眼紋病 (Pseudocercosporella herpotrichoides) 、 雲形病 (Rhynchosporium secalis)、葉枯病(Septoria tritici)、穎枯 病(Leptosphaeria nodorum)、腐霉屬菌(Pythium)引起之褐色雪 腐病(Pythium iwayamai 等); 葡萄之露菌病(Plasmopara viticora)、白粉病(Uncinula necator)、黑痘病(Elisinoe ampelina)、晚腐病(Glomerella 15 200916444 cingulata)、錄病(Phakopsora ampelopsidis); 蘋果之白粉病(Podosphaera leucotricha)、黑星病(Venturia inaequalis)、斑點落葉病(Alternaria alternata、apple pathotype)、赤星病(Gymnosporangium yamadae)、Monilia 病 (Sclerotinia mali)、腐爛病(Valsa ceratosperma); 梨之黑斑病(Alternaria alternata 、 Jpanese pear pathotype)、黑星病(Venturia nashicola)、赤星病 (Gymnosporangium haraeanum); 西洋梨之疫病 P (hytophthora cactorum); r 桃之褐腐病(Sclerotinia cinerea)、黑星病(Cladosporium carpophilum)、黑潰瘍菌腐敗病(Phomopsis sp.)、疫病 (Phytophthora sp.); 柿之炭疽病(Colletotrichum gloeosporioides)、落葉病 (Cercospora kaki; Mycosphaerella nawae); 瓜類之露菌病(Psudoperonospora cubensis)、疫病 (Phytophthora meIonis 、 Phytophthora nicotianae 、 Phytophthora drechsleri)、白粉病(Sphaerotheca fuliginea)、 炭疽病(Colletotrichum lagenarium)、蔓枯病(Mycosphaerella m r\ 1 ^ * niv^ i uni oy , 番茄之晚疫病(Phytophthora infestans)、苗立枯病 (Pythium vezans &amp; Rhizoctonia solani)、早疫病(Alternaria solani)、葉黴病(Fluvia fulva)、根腐病(Pythium myriotylum &amp; Pythium dissotocum); 茄子之白粉病 (Erysiphe cichoracorum)、晚疫病 (Phytophthora infestans)、果腐疫病(Phytophthora capsici); 十字花料蔬菜之黑斑病(Alternaria japonica)、白斑病 (Cercosporella brassicae)、根瘤病(Plasmodiophora brassicae)、露菌病(Peronospora brassicae); 蔥之白色疫病(Phytophthora porri)、銹病(Puccinia .allii); 16 200916444 大豆之莖疫病 (Phytophthora megasperma)、露菌病 (Peronospora manshurica)、紫斑病(Cercospora kikuchii)、黑 疫病(Elisinoeglysines)、黑點病(Diaporthephaseololum); 菜豆之炭症病(Colletotrichum lindemuthianum); 落花生之黑溫病(Mycosphaere 11 a berke 1 ey i i)、褐斑病 (Mycosphaerella arachidis); 婉豆之白粉病(Erysiphe pisi)、露菌病(Peronospora pisi); 馬鈴薯之晚疫病(Phytophthora infestans)、早疫病 (Alternaria solani); 茶之網餅病(Exobasidiumreticulatum)、白星病(Elisinoe leucospila); 於草之赤星病(Alternaria longipes)、白粉病(Erysiphe cichoracearum)、炭疽病(Colletotrichum tabacum); 甜菜之褐斑病(Cercospora beticola)、露菌病(Peronospora schachtii); 玫瑰之黑斑病(Diplocarpon rosae)、露菌病(Peronospora sparsa)、疫病(Phytophthora megasperma)、白粉病 (Sphaerotheca pannosa); 菊之褐斑病(Septoria chrysanthemi-indici)、白錄病 (Puccinia horiana)、疫病(Phytophthora catctorum); 草莓之白粉病(Sphaerotheca humuli)、疫病(Phytophthora nicotianae)、果腐病(Pythium ulutimum); 胡瓜、番%、草莓、葡萄等之灰黴病(Botrytis cinerea)、 囷核病(Sc 1 erot i n i a sc 1 erot i orum ); 草皮之褐斑病(Rhizoctonia solani)、錢點病(Sclerotinia homoeocarpa)、(彎孢菌)葉枯病(Curvularia geniculata)、錄 病(Puccinia zoysiae)、Helminthosporium(長蠕抱菌)葉枯病 (Cochiliobolus sp.)、雲形病(Rhynchosporium secalis)、稻 熱病(Magnaporthe grisea(Pyricularia oryzae))、立枯病 17 200916444 (Gaeumannoinyces graminis)、炭疽病(Coilet〇trichum 'graminicola)、雪腐褐色小粒菌核病(Typhula incarnate)、帝 腐黑色小粒®核病(Typhula ishikariensis)、雪腐大粒菌核^ ^clerotima boreaiis)、仙女環病(Marasmius 〇reades )、 霉病(Pythium aphanidermatum)等等。 &quot; 其中,一般式⑴表不之吼唾叛酸衍生物,對水稻稻孰病 grisea(Pyricularia 町就))尤其表現優異= 仏础本發明之殺_之使用方式並無特驅制,如存用於針播 本發明之殺菌劑可單獨使用,或亦可當做^ 質之混合製劑使用。乃即射辰条均改良劑或肥效性物 又’在本發明之殺菌劑’其0比唾舰衍生物 ^別限制’如可直接含有吼哇舰衍生物 ='、、、 體或液__之_混合讀成物巾 2 3在與包3固 ,物以含在上述組成物中較好。在此,所;:二^酸街 =達須處理部位,或為使有效成分化 方便而配合之合成或天然之無機或有機物質。、丁存輪达及知作 在本發明,適合之固體 (_tmorillonite)、高嶺土 ^舉^如蒙脫石 滑石粉、經石(vermiculite)、石*、石類’㈣土、白土、 機物質:大,粉、小麥粉等植物4機以及:#。、硫安等無 適合之液體载體可舉例如甲苯、二 昱、 烴類;媒油、確物油等石蠛系烴類;四^;(c?r) 一:,等齒化烴類;丙鲷、曱乙酮 ;Ί仿、 :甘醇二甲醚等醚類;甲醇、乙一 i、四氳呋喃、 基甲醯胺、二甲亞砜、i 夂乙一醇等醇類;二甲 劑及水等。 m轉明轉質子性極性溶 本發明之殺_可再含有各種輔助劑。輔助财因應目的而 18 200916444 用。 輔助士此相助劑可單獨使用或2種以上組合使 聚氧稀烴燒基疏酸趟及^嫌:鹽、烧基硫酸醋鹽、 性劑;聚氧_燒=陰離子界面活 聚氧烯烴絲酿胺氧稀烴烧基胺、 脂肪酸酿、山梨糖醇肝二:::氧:酸酿、甘油 及聚氧丙烯聚氧乙烯後段聚人雜醇酐脂肪酸賴 甲基纖維素、酪蛋白、阿^立腆/哲二、甲基纖維素、羧 於上述者。 &gt; 4。但此專輔助劑成分並不限定 本發明之殺菌劑中— 量,通常在粉劑為〇.5〜2(^^OS3°f幾酸衍生物之含 性粉劑為〇 5〜90重旦 。礼知為〇· 5〜50重量%,可渴Cdiaza-bicyclo-undecene) and other organic tests.埽 When a base is used in the reaction formula (2), it can be used as a solvent of the reaction formula (2) when it is used in an amount of an organic base. ..., meaning j. In particular, the reaction temperature and reaction time of the above reaction formula (2) are used. In general, the reaction temperature is -赃~·. c, and then change again, the reaction time is 〇. 〇 1~50 hours, and 15 hours is better.化合物 The compound represented by the above formula (4) can be produced by the above-mentioned carboxylic acid. For example, the above-mentioned general formula (2) is represented by (four) ϊ^ί, gas, phosgene, chlorinated scale, three gasification disc, five gasified phosphorus: bromine, phosphorus tribromide, diethylamine Sulfur fluoride, ], imidazole, etc. are produced by reaction. Further, the compound represented by the general formula (4) can be reacted with an alcohol represented by the general formula (2) and an alcohol such as methanol or ethanol in the absence of a catalyst or a catalyst according to a usual method. &lt;Fungicide&gt; 14 200916444 • A fungus containing at least one of the above-mentioned general formula (1), which is represented by the above formula (1), as an active ingredient. According to this, the role of plant diseases in the age of health can be controlled. The use of the bactericide of the present invention is not particularly limited, and it can be used as an industrial bactericide for antisepsis, mildew resistance, etc., a bactericidal agent for agricultural and horticultural use, a sterilizing agent for medical use, and the like. Since the fungicide of the present invention exhibits a plant disease control effect, it is particularly preferred as a fungicide for agricultural and horticultural use. + The bactericide of the present invention can be used for belonging to the order of the genus Oomycetes, Ascomycetes, incomplete genus (j) euteromycetes, Basidiomycetes, and the genus Piasm〇di〇 ph〇romyCetes) and various plant diseases caused by other pathogens such as vegetables, fruit trees, rice, cereals, flowers, and turf. Next, the specific disease name (pathogenic name) which can use the fungicide of the present invention is exemplified as a non-limiting example. Rice blast disease (Magnaporthe grisea (Pyricularia oryzae)), flax leaf blight (Cochliobolus miyabeanus), Rhizoctonia solani, Gibberella fujikuroi, Pythium iKPythium (Pythium graminicola, etc.); powdery mildew of wheat (Erysiphe gramiis f.sp. hordei; f.sp. triici), Pyrenophora graminea, Pyrenophora teres (net spot), scab ( Gibberella zeae), rust (Puccinia striiformis; P. graminis i P. recondite i P. hordei), snow rot (Typhula sp. &amp; Micronectriella nivalis), smut (Ustilago tritici &amp; U. nuda), eye Pseudocercosporella herpotrichoides, Rhynchosporium secalis, Septoria tritici, Leptosphaeria nodorum, Pythium brown rot (Pythium iwayamai, etc.); Grape Plasmopara viticora, Uncinula necator, Elisinoe ampelina, late rot (Glomerella 15 200916444 ci Ngulata), Phakopsora ampelopsidis; Podosphaera leucotricha, Venturia inaequalis, Alternaria alternata, apple pathotype, Gymnosporangium yamadae, Monlia disease (Sclerotinia mali) ), rot (Valsa ceratosperma); pear black spot disease (Alternaria alternata, Jpanese pear pathotype), black star disease (Venturia nashicola), brown spot disease (Gymnosporangium haraeanum); Pear disease P (hytophthora cactorum); r peach Brown rot (Sclerotinia cinerea), Scadosporium carpophilum, Phomopsis sp., Phytophthora sp.; Colletotrichum gloeosporioides, deciduous disease (Cercospora kaki; Mycosphaerella nawae); Psudoperonospora cubensis, Phytophthora meIonis, Phytophthora nicotianae, Phytophthora drechsleri, Sphaerotheca fuliginea, Colletotrichum lagenarium, Bacterial wilt (Mycosphaerella mr\ 1 ^ * niv^ i Uni oy , Phytophthora infestans, Pythium vezans &amp; Rhizoctonia solani, Alternaria solani, Fluvia fulva, Pythium myriotylum & Pythium dissotocum ); Erysiphe cichoracorum, Phytophthora infestans, Phytophthora capsici; Alternaria japonica, Cercosporella brassicae, Plasmodiophora Brasicae), Peronospora brassicae; Phytophthora porri, rust (Puccinia.allii); 16 200916444 Phytophthora megasperma, Peronospora manshurica, purple spot (Cercospora) Kikuchii), Elisinoeglysines, Diaporthephaseololum; Colletotrichum lindemuthianum; Mycosphaere 11 a berke 1 ey ii, Mycosphaerella arachidis; Bean powdery mildew (Erysiphe pisi), dew disease ( Peronospora pisi); Phytophthora infestans, Alternaria solani; Exobasidium reticulatum, Elisinoe leucospila; Alternaria longipes, powdery mildew (Erysiphe) Cichoracearum), Colletotrichum tabacum; Cercospora beticola, Peronospora schachtii; Diplocarpon rosae, Peronospora sparsa, Phytophthora megasperma ), powdery mildew (Sphaerotheca pannosa); Sepia chrysanthemi-indici, Puccinia horiana, Phytophthora catctorum; Sphaerotheca humuli, Phytophthora nicotianae, Pythium ulutimum; Botrytis cinerea, Sc 1 erot inia sc 1 erot i orum; Rhizoctonia solani , Sclerotinia homoeocarpa, Curvularia (Curvularia) Geniculata), Puccinia zoysiae, Helminthosporium, Cochiliobolus sp., Rhynchosporium secalis, Magnaporthe grisea (Pyricularia oryzae), Blight 17 200916444 ( Gaeumannoinyces graminis), Anthracnose (Coilet〇trichum 'graminicola), Typhula incarnate, Typhula ishikariensis, Xcleostima boreaiis, Fairy Marasmius 〇reades, Pythium aphanidermatum, etc. &quot; Among them, the general formula (1) shows that the sputum acid derivative is particularly excellent for the rice blast grisea (Pyricularia), and there is no special drive for the use of the invention. The bactericide used in the present invention may be used alone or as a mixed preparation of the substance. That is, the shots are all improved or fertilized and 'in the fungicide of the present invention', the 0 is more limited than the saliva derivative, such as can directly contain the wow ship derivative = ',,, body or liquid _ The mixed-filled towel 2 3 is preferably solidified with the bag 3 to be contained in the above composition. Here, it is a synthetic or natural inorganic or organic substance that is required to be treated in a convenient manner to facilitate the active ingredient. In the present invention, suitable for solid (_tmorillonite), kaolin ^ ^ such as montmorillonite talcum powder, vermiculite, stone *, stone 'four soil, white clay, organic matter: Large, powder, wheat flour and other plants 4 machines and: #. Examples of liquid carriers which are not suitable for sulfur, such as toluene, dioxane, hydrocarbons; kerocene hydrocarbons such as kerosene and oils; tetrakis; (c?r) a: an isocyanated hydrocarbon; Propylene, acetophenone; imitation, ethers such as glyme; alcohols such as methanol, ethyl i, tetrahydrofuran, carbamazepine, dimethyl sulfoxide, i- acetyl ethoxylate; And water, etc. M-transfer to proton polar solution The killer of the present invention may further contain various adjuvants. Auxiliary financial purposes should be used 18 200916444. Auxiliary agent can be used alone or in combination of two or more kinds to make polyoxyalkylene sulphonate and sulphur: salt, sulphuric acid sulphate, agent; polyoxy- sinter = anionic interface polyoxy olefin wire Amine oxyalkylene amide, fatty acid brewing, sorbitol liver II::: Oxygen: acid brewing, glycerin and polyoxypropylene polyoxyethylene late stage poly-alcoholic fatty acid lysyl methyl cellulose, casein, A腆 / Zhe II, methyl cellulose, carboxy in the above. &gt; 4. However, the specific adjuvant component is not limited to the amount of the fungicide of the present invention, and is usually in the powder of 〇.5~2 (^^OS3°f acid derivative is 〇5~90 heavy denier. Know as 〇 · 5~50% by weight, can be thirsty

〜⑽趟.,但==1〜2°重量級水懸浮劑為U % ; J 60^99 tt ,重量級水10〜9_,粒綱 常粉劑為0· 1〜20重量%',·]卞丨f里t又’關於辅助劑含量,通 -20 ί#% , ί*! °· 1 J :等載體含量、辅助劑含量里』’二1以丄〜加重量%。 性、應用場所等而適當調節。 疋了考慮製劑之理化 「實施例」 限定以:用不受此等實施例之 (實施例丨)」4貝里基準,除非另有說明。 氟甲基- 1Η - t»比嗤-5 __ 、,〈合成卜甲基-恥正辛基_3_ 幾醒胺(化合物編號57) &gt; 19 200916444 加亞硫醯氣l〇mL於i—甲美 一 •羧酸l.〇g,加熱回流2祕一甲基—H—吡唾-5〜 減壓下顧除㈣點物。、° ^過狀亞硫醯紐,加笨,在 喃Hm”. 81㈣解於四氫呋 狀態在冰冷下攪拌30分鐘了月 之四風吱喃溶液祉。以此 溶液注入财巾1 在室溫下獅4树。將此反應 機液層以硫酸鎮乾烊,甲烧3GGmL萃取2次後,其有 精製(溶劑1匕,谷劑。所得殘渣以矽膠管柱層析法 (實茶色固體之標題化合物h呢。 〈合成1-甲基-N-正辛基—3_三氟甲基_11{_吡啥 羧醯胺(化合物編號57) &gt; 5 其甲基_ 3 ~二氣甲基—1H 一吼唾—5 一羧酸h收及正辛 ^ Ulg溶解於四氫料觀後,在冰冷下加卜乙基〜 4丨0士4 Y基胺丙基^反化二亞胺·鹽酸鹽l lg。在室溫下攪拌 二it L加二氯曱烷200mL ’並用水洗滌。其有機液層以硫酸鎂 上容劑:所得殘逢以石夕膠管柱層析法精製(洗提溶劑:二 虱甲烷/己烷),得淡茶色固體之標題化合物1. 0g。 、以下將㈣與上述實施例1及實施例2服製造之化合龄; 即以下列般式⑸〜—般式⑻表示之化合物例分別*如表1〜 表11。並將其中幾個化合物之物性值示如表12〜表19。 又,表中記載之Me為曱基,Et為乙基,i-Pr為異丙基,n_Pr =丙基’ n - Bu為正丁基,c _ Hex為環己基,Bn為节基,ph為 笨土,vinyl為乙烯基,anyi為烯丙基,pr〇pargyl為炔丙基, Ac為乙醯基’ Bz為笨曱醯基,Naph為萘基。 20 200916444 【表1】 R2~(10)趟., but ==1~2° heavyweight water suspension agent is U % ; J 60^99 tt , heavyweight water 10~9_, granules of normal powder is 0·1~20% by weight ',·]卞丨f in the t and 'about the adjuvant content, pass -20 ί#%, ί*! °· 1 J: and other carrier content, adjuvant content in the 'two 1 to 丄 ~ plus weight%. Appropriate adjustment of sex, application place, etc. Having considered the physical and chemical properties of the formulation, the "Examples" are defined as: 4 mils basis without (Example 丨)" of these examples unless otherwise stated. Fluoromethyl- 1Η-t»比嗤-5 __ ,, <Synthesis of methyl-disc-octyl _3_ kinamine (Compound No. 57) &gt; 19 200916444 Addition of sulfazone x〇mL in i-甲美A • carboxylic acid l. 〇g, heated reflux 2 secret one methyl-H-pyrazole-5~ Under the decompression, take care of (four) points. , ° ^ 亚 亚 醯 醯 , 加 加 加 加 加 加 加 , , , , , , , , , , , 81 81 81 81 81 81 81 81 81 81 81 81 81 81 81 81 81 81 81 81 81 81 81 81 81 81 81 81 81 81 Wenxia Lion 4 tree. The liquid layer of this reactor was dried with sulphuric acid, and after 2 times of extraction with 3 GGmL of formazan, it was refined (solvent 1 匕, gluten. The residue obtained was obtained by gel column chromatography (solid brown solid) The title compound h. <Synthesis of 1-methyl-N-n-octyl-3-trifluoromethyl_11{_pyridinium carboxamide (Compound No. 57) &gt; 5 Its methyl _ 3 ~ two gas Methyl-1H 吼 吼 — 5 一 一 一 一 Ul Ul Ul Ul Ul Ul Ul Ul Ul Ul Ul Ul Ul Ul Ul Ul Ul Ul Ul Ul Ul Ul Ul Ul Ul Ul Ul Ul Ul Ul Ul Ul Ul Ul Ul Ul Ul Ul Ul Ul Ul Ul Hydrochloride l lg. Stir two liters of dichlorosilane (200 mL) at room temperature and wash with water. The organic layer was treated with magnesium sulfate. The residue was purified by Shixi rubber column chromatography (washing) Solvent: di-methane/hexane), the title compound of the pale brown solid is 1.0 g, and the following (4) is combined with the above-mentioned Example 1 and Example 2 to produce the same age; that is, the following formula (5)~ Formula (8) The compound examples shown are as follows: Table 1 to Table 11. The physical property values of several of the compounds are shown in Table 12 to Table 19. Further, Me in the table is a mercapto group, Et is an ethyl group, and i-Pr is Isopropyl, n_Pr = propyl ' n - Bu is n-butyl, c _ Hex is cyclohexyl, Bn is a benzyl group, ph is stupid, vinyl is vinyl, anyi is allyl, pr〇pargyl is alkyne Propyl, Ac is ethyl ketone group 'Bz is a ruthenium group, and Naph is a naphthyl group. 20 200916444 [Table 1] R2

\R4 (5) 化合物 編號 R 1 R 2 R 3 R4 1 Me CF3 H i-Pr 2 Me CF3 H n-Bu 3 Me CF3 H n-C8H17 4 Me CF3 H c-Hex 5 Me CF3 H al ly 1 6 Me CF3 H propargy1 7 Me CF3 H Ph 8 Me CF3 H cf3 \ Me 9 Me CF3 H Υλ 10 ' Me CF3 H 七 11 Me CF3 H o 12 H CF3 H c-Hex 13 H CF3 H Ph 14 Me CF3 Cl c-Hex 15 Me CF3 Cl Ph 16 Et CF3 H c-Hex 17 Et CF3 H Ph 18 i-Pr CF3 H c-Hex 19 i-Pr CF3 H Ph 20 Me i-C3F7 H c-Hex 21 Me i-C3F7 H Ph 22 Me CF3 H n-C12H25 21 200916444 【表2】 R2\R4 (5) Compound No. R 1 R 2 R 3 R4 1 Me CF3 H i-Pr 2 Me CF3 H n-Bu 3 Me CF3 H n-C8H17 4 Me CF3 H c-Hex 5 Me CF3 H al ly 1 6 Me CF3 H propargy1 7 Me CF3 H Ph 8 Me CF3 H cf3 \ Me 9 Me CF3 H Υλ 10 ' Me CF3 H VII 11 Me CF3 H o 12 H CF3 H c-Hex 13 H CF3 H Ph 14 Me CF3 Cl c- Hex 15 Me CF3 Cl Ph 16 Et CF3 H c-Hex 17 Et CF3 H Ph 18 i-Pr CF3 H c-Hex 19 i-Pr CF3 H Ph 20 Me i-C3F7 H c-Hex 21 Me i-C3F7 H Ph 22 Me CF3 H n-C12H25 21 200916444 [Table 2] R2

R5 化合物 編號 R 1 R 2 R3 R5 23 Me CF3 H Me 24 Me CF3 H Et 25 Me CF3 H i-Pr 26 Me CF3 H n-Bu 27 Me CF3 H n-C8H17 28 Me CF3 H c-Hex 29 Me CF3 H al lyl 30 Me CF3 H propargyI 31 Me CF3 H Ph 32 Me CF3 H CFa \ Me 33 Me CF3 H 34 Me CF3 Lj -o 35 Me CF3 H -^;3 36 H CF3 H Me 37 H CF3 H c-Hex 38 H CF3 H Ph 39 Me CF3 Cl Me 40 Me CF3 Cl c-Hex 41 Me CF3 Cl Ph 42 Me CF3 N02 Me 43 Me CF3 CN Me 44 Me CF3 Me Me 45 Me CF3 OMe Me 46 Me CF3 S02Me Me 22 200916444 【表3】 化合物 編號 R 1 R 2 R 3 R 5 47 Et CF3 H Me 48 Et CF3 H c-Hex 49 Et CF3 H Ph 50 i-Pr CF3 H Me 51 i-Pr CF3 H c-Hex 52 i-Pr CF3 H Ph 53 Me n-C3F7 H Me 54 Me i-C3F7 H Me 55 Me i-C3F7 H c-Hex 56 Me i-C3F7 H Ph 23 200916444 【表4】R5 Compound No. R 1 R 2 R3 R5 23 Me CF3 H Me 24 Me CF3 H Et 25 Me CF3 H i-Pr 26 Me CF3 H n-Bu 27 Me CF3 H n-C8H17 28 Me CF3 H c-Hex 29 Me CF3 H al lyl 30 Me CF3 H propargyI 31 Me CF3 H Ph 32 Me CF3 H CFa \ Me 33 Me CF3 H 34 Me CF3 Lj -o 35 Me CF3 H -^;3 36 H CF3 H Me 37 H CF3 H c-Hex 38 H CF3 H Ph 39 Me CF3 Cl Me 40 Me CF3 Cl c-Hex 41 Me CF3 Cl Ph 42 Me CF3 N02 Me 43 Me CF3 CN Me 44 Me CF3 Me Me 45 Me CF3 OMe Me 46 Me CF3 S02Me Me 22 200916444 Table 3] Compound No. R 1 R 2 R 3 R 5 47 Et CF3 H Me 48 Et CF3 H c-Hex 49 Et CF3 H Ph 50 i-Pr CF3 H Me 51 i-Pr CF3 H c-Hex 52 i-Pr CF3 H Ph 53 Me n-C3F7 H Me 54 Me i-C3F7 H Me 55 Me i-C3F7 H c-Hex 56 Me i-C3F7 H Ph 23 200916444 [Table 4]

(7) 化合物 編號 R 1 R2 R 3 R6 R7 57 Me CF3 H H n-C8H17 58 Me CF3 H H n-C12H25 59 Me CF3 H H CH(CH3)C6H13 60 Me CF3 H Me n-C8H17 61 Me CF3 H H vinyl 62 Me CF3 H H al lyI 63 Me CF3 H H propargyI 64 Me CF3 H Ph Ph 65 Me CF3 H c-Hex Ph 66 Me CF3 H Ac Ph 67 Me CF3 H 0丫 iPr Ph 68 Me CF3 H Bz Ph 69 Me CF3 H CoiPr Ph 70 Me CF3 H COOMe Ph 71 Me CF3 H COOPh Ph 72 Me CF3 H S02Me Ph 73 Me CF3 H S02Ph Ph 74 Me CF3 H CONHMe Ph 75 Me CF3 H C0NMe2 Ph 76 Me CF3 H CONHiPr Ph 77 Me CF3 H CONHPh Ph 79 Me CF3 H Me 0 Ph 80 Me CF3 H Ό Me 0 81 Me CF3 Cl CF„ Cl Me 0 Ph 24 200916444 【表5】 化合物 編號 R 1 R 2 R3 R 6 R7 82 Me CF3 Cl CF Cl Me 0 NC 83 Me CF3 H H Me C00H 84 Me CF3 H H Me 人 Me COOH 85 Me CF3 H H Me 'Xj^XMe COOH 86 Me CF3 H H COOH 87 Me CF3 H H COOH 88 Me CF3 H H Me COOH 89 Me CF3 H H Et COOH 90 Me CF3 H H COOH Me 91 Me CF3 H H Ύ&quot; COOH 92 Me CF3 H H COOH 93 Me CF3 H H Me COOMe 25 200916444 【表6】 化合物 編號 R 1 R 2 R 3 R 6 R 7 94 Me CF3 H H Me 、,人 Me COOMe 95 Me CF3 H H Me COOMe 96 Me CF3 H H \^Me COOEt 97 Me CF3 H H COOEt 98 Me CF3 H H 丫 Me COOEt 99 Me CF3 H H Et COOiPr 100 Me CF3 H H COOiPr Me 101 Me CF3 H H vEt COOnPr 102 Me CF3 H H COOnBu 103 Me CF3 H MeS02 Ph 104 Me CF3 H Vcl Ph 105 Me CF3 H Ph 106 Me CF3 H COOiPr Ph 107 Me CF3 H COOBn Ph 108 Me CF3 H C00CH2CF3 Ph 26 200916444 【表7】 化合物 編號 R 1 R 2 R3 R 6 R 7 109 Me CF3 H 人XT Ph 110 Me CF3 H 人 Ph 111 Me CF3 H 0、、,P Ph 112 Me CF3 H O7 ά;&gt; 113 Me CF3 H S02Ph 114 Me CF3 H S02Ph Me 115 Me CF3 H S02PH X 116 Me CF3 H S02Ph XJ ' 117 Me CF3 H S02Ph 118 Me CF3 H S02Ph jX 119 Me CF3 H cf'o Ph 120 Me CF3 H oA) Ph 121 Me CF3 H S02n-Bu Ph 27 200916444 【表8】 化合物 編號 R 1 R 2 R3 R 6 R7 122 Me CF3 H S02Ph 123 Me CF3 H S02Ph n-Bu 124 Me CF3 H S02Ph Bn 125 Me CF3 H S02 Bn Ph 126 Me CF3 H S02Ph n-Hex 127 Me CF3 H S02Ph MeO IVL 128 Me CF3 H S02Ph 129 Me CF3 H S02n-0ct Ph 130 Me CF3 H S02n-Bu n-Oct 131 Me CF3 H H n-Hex 132 Me CF3 H H n-Dec 133 Me CF3 H H n-Hep 134 Me CF3 H H n-Non 135 Me CF3 H S02Ph XT2 136 Me CF3 H S02Ph jT 137 Me CF3 H H He Me ^&quot;COOEt 138 Me CF3 H H 9 ’、COOMe 139 Me CF3 H H Me Me •^^COOMe 140 Me CF3 H H Me ^k^COOEt 141 Me CF3 H S02PH ~0~Me 142 Me CF3 H S02Ph _hO_ci 143 Me CF3 H S02Ph n-C8H17 28 200916444 【表9】(7) Compound No. R 1 R2 R 3 R6 R7 57 Me CF3 HH n-C8H17 58 Me CF3 HH n-C12H25 59 Me CF3 HH CH(CH3)C6H13 60 Me CF3 H Me n-C8H17 61 Me CF3 HH vinyl 62 Me CF3 HH al lyI 63 Me CF3 HH propargyI 64 Me CF3 H Ph Ph 65 Me CF3 H c-Hex Ph 66 Me CF3 H Ac Ph 67 Me CF3 H 0丫iPr Ph 68 Me CF3 H Bz Ph 69 Me CF3 H CoiPr Ph 70 Me CF3 H COOMe Ph 71 Me CF3 H COOPh Ph 72 Me CF3 H S02Me Ph 73 Me CF3 H S02Ph Ph 74 Me CF3 H CONHMe Ph 75 Me CF3 H C0NMe2 Ph 76 Me CF3 H CONHiPr Ph 77 Me CF3 H CONHPh Ph 79 Me CF3 H Me 0 Ph 80 Me CF3 H Ό Me 0 81 Me CF3 Cl CF„ Cl Me 0 Ph 24 200916444 [Table 5] Compound No. R 1 R 2 R3 R 6 R7 82 Me CF3 Cl CF Cl Me 0 NC 83 Me CF3 HH Me C00H 84 Me CF3 HH Me Human Me COOH 85 Me CF3 HH Me 'Xj^XMe COOH 86 Me CF3 HH COOH 87 Me CF3 HH COOH 88 Me CF3 HH Me COOH 89 Me CF3 HH Et COOH 90 Me CF3 HH COOH Me 91 Me CF3 HH Ύ&quot; COOH 92 Me CF3 HH COOH 93 Me CF3 HH Me COOMe 25 200916444 [Table 6] Compound No. R 1 R 2 R 3 R 6 R 7 94 Me CF3 HH Me,,Me MeOMOM 95 Me CF3 HH Me COOMe 96 Me CF3 HH \^Me COOEt 97 Me CF3 HH COOEt 98 Me CF3 HH 丫Me COOEt 99 Me CF3 HH Et COOiPr 100 Me CF3 HH COOiPr Me 101 Me CF3 HH vEt COOnPr 102 Me CF3 HH COOnBu 103 Me CF3 H MeS02 Ph 104 Me CF3 H Vcl Ph 105 Me CF3 H Ph 106 Me CF3 H COOiPr Ph 107 Me CF3 H COOBn Ph 108 Me CF3 H C00CH2CF3 Ph 26 200916444 [Table 7] Compound No. R 1 R 2 R3 R 6 R 7 109 Me CF3 H Human XT Ph 110 Me CF3 H Human Ph 111 Me CF3 H 0,,,P Ph 112 Me CF3 H O7 ά;&gt; 113 Me CF3 H S02Ph 114 Me CF3 H S02Ph Me 115 Me CF3 H S02PH X 116 Me CF3 H S02Ph XJ ' 117 Me CF3 H S02Ph 118 Me CF3 H S02Ph jX 119 Me CF3 H cf'o Ph 120 Me CF3 H oA) Ph 121 Me CF3 H S02n-Bu Ph 27 200916444 [Table 8] Compound No. R 1 R 2 R3 R 6 R7 122 Me CF3 H S02Ph 123 Me CF3 H S02Ph n-Bu 124 Me CF3 H S02Ph Bn 125 Me CF3 H S02 Bn Ph 126 Me CF3 H S02Ph n- Hex 127 Me CF3 H S02Ph MeO IVL 128 Me CF3 H S02Ph 129 Me CF3 H S02n-0ct Ph 130 Me CF3 H S02n-Bu n-Oct 131 Me CF3 HH n-Hex 132 Me CF3 HH n-Dec 133 Me CF3 HH n-Hep 134 Me CF3 HH n-Non 135 Me CF3 H S02Ph XT2 136 Me CF3 H S02Ph jT 137 Me CF3 HH He Me ^&quot;COOEt 138 Me CF3 HH 9 ',COOMe 139 Me CF3 HH Me Me •^^COOMe 140 Me CF3 HH Me ^k^COOEt 141 Me CF3 H S02PH ~0~Me 142 Me CF3 H S02Ph _hO_ci 143 Me CF3 H S02Ph n-C8H17 28 200916444 [Table 9]

化合物 編號 R 1 R2 R3 R8 R 9 R 1 0 144 Me CF3 H H H Me 145 Me CF3 H Me H H 146 Me CF3 H H H c-Hex 147 Me CF3 H H H Allyl 148 Me CF3 H H H Propargyi 149 Me CF3 H Me H H 150 Me CF3 H H H Ph 151 Me CF3 H Ph H H 152 Me CF3 H H Me Ph 153 Me CF3 H H -(CH2) 5- 154 Me CF3 H H -(CH2)2-0-(CH2) 2- 155 Me CF3 H Ac H Ph 156 Me CF3 H Bz H Ph 157 Me CF3 H H Ac Ph 158 Me CF3 H H Bz Ph 159 H CF3 H H H Me 160 H CF3 H H H c-Hex 161 H CF3 H H H Ph 162 Me CF3 Cl H H Ph 163 Me CF3 N02 H H Ph 164 Me CF3 CN H H Ph 165 Me CF3 Me H H Ph 166 Me CF3 OMe H H Ph 167 Me CF3 S02Me H H Ph 168 Et CF3 H H H Me 169 Et CF3 H H H c-Hex 170 Et CF3 H H H Ph 171 i-Pr GF3 μ H H Me 172 i-Pr CF3 H H H c-Hex 173 i-Pr CF3 H H H Ph 174 Me n-C3F7 H H H Me 175 Me n-C3F7 H H H Ph 176 Me i-C3F7 H H H Me 177 Me i-C3F7 H H H Ph 29 200916444 【表10】Compound No. R 1 R2 R3 R8 R 9 R 1 0 144 Me CF3 HHH Me 145 Me CF3 H Me HH 146 Me CF3 HHH c-Hex 147 Me CF3 HHH Allyl 148 Me CF3 HHH Propargyi 149 Me CF3 H Me HH 150 Me CF3 HHH Ph 151 Me CF3 H Ph HH 152 Me CF3 HH Me Ph 153 Me CF3 HH -(CH2) 5- 154 Me CF3 HH -(CH2)2-0-(CH2) 2- 155 Me CF3 H Ac H Ph 156 Me CF3 H Bz H Ph 157 Me CF3 HH Ac Ph 158 Me CF3 HH Bz Ph 159 H CF3 HHH Me 160 H CF3 HHH c-Hex 161 H CF3 HHH Ph 162 Me CF3 Cl HH Ph 163 Me CF3 N02 HH Ph 164 Me CF3 CN HH Ph 165 Me CF3 Me HH Ph 166 Me CF3 OMe HH Ph 167 Me CF3 S02Me HH Ph 168 Et CF3 HHH Me 169 Et CF3 HHH c-Hex 170 Et CF3 HHH Ph 171 i-Pr GF3 μ HH Me 172 i-Pr CF3 HHH c-Hex 173 i-Pr CF3 HHH Ph 174 Me n-C3F7 HHH Me 175 Me n-C3F7 HHH Ph 176 Me i-C3F7 HHH Me 177 Me i-C3F7 HHH Ph 29 200916444 [Table 10]

化合物 編號 R 1 R 2 R3 R8 R 9 R 1 0 178 Me CF3 H H H cf3 \ Me 179 Me CF3 H H H CN 180 Me CF3 H H H &gt;&gt; 181 Me CF3 H H H Me 182 Me CF3 H H COOMe Ph 183 Me CF3 H H COOPh Ph 184 Me CF3 H H S02Me Ph 185 Me CF3 H H S02Ph Ph 186 Me CF3 u u GONHMe Ph 187 Me CF3 H Ph CONHPh H 188 Me CF3 H H H X) 189 Me CF3 H H H XTMe 190 Me CF3 H XrMe H H 191 Me C'F3 jCT 192 Me CF3 H XT H H 30 200916444 【表11】 化合物 編號 R 1 R 2 R3 R8 R 9 R 1 0 193 Me CF3 H H H Bz 194 Me CF3 H H Ph Ph 195 Me CF3 H H H CONHPh 196 Me CF3 H Me H f3c 197 Me CF3 H H H FsQ W lie 0 198 Me CF3 H H H ^aCN 199 Me CF3 H H S02Ph f3c w fie 0 200 Me CF3 H H Me Me 201 Me CF3 H Bz Bz Ph 202 Me CF3 H Ac Ac Ph 203 Me CF3 l_j u -G(C02Me)=CH-CH=CH- 204 Me CF3 H H H 3 205 Me CF3 H H H 206 Me CF3 H H h 207 Me CF3 H H - (CH2)5- 31 200916444 【表12】 化合物編號 物性値 3 Ή NMR (CDCI3) δ 0.89 (3Η, t, ^6.8Ηζ), 1.24-1.45 (10H, m), 1.71-1.78 (2H, m), 4.23 (3H, s), 4.31 (2H, t, 〇ί=6.8Ηζ), 7.07 (1H, s). 4 Ή NMR (CDCI3) &lt;5 1.29-1.49 (4H. m), 1.52-1.62 (2H, m), 1.76-1.80 (2H. m), 1.91-1.96 (2H, m), 4.23 (3H, s), 4.97-5.04 (1H. m), 7.07 (1H, s). 7 'HNMR(CDCg &lt;5 4.28 (3H, s), 7.17-7.24 (2H, m), 7.29-7.32 (2H, m), 7.43-7.48 (2H, m). 8 Ή NMR (CDCI3) δ 4.01 (3H, s), 4.25 (3H, s), 5.35 (2H, s), 6.56 (1H, s), 7.08 (1H, s)_ m.p.: 75.2-77.6°C 9 Ή NMR (CDCI3) δ 2.48 (3H, s), 4.29 (3H, s), 6.23 (1H, s), 7.35 (1H, s). m.p.: 31-33°C 10 Ή NMR (CDCI3) 6 4.29 (3H, s), 7.17 (1H, d, 〇/=7.3Ηζ), 7.32-7.35 (2H, m), 7.86-7.91 (1H,m), 8.48(1 H,m) m.p.: 58.4-60.8°C 11 1H NMR (CDCI3) δ 4.30 (3H, s), 7.37-7.40 (2H, m), 8.82 (2H, d, l/=4.9Hz) 22 Ή NMR (CDC!3) &lt;5 0.88 (3H, t, u/=6.8Hz), 1.26-1.41 (2H, septet, J =7.3Hz), 1.50-1.60 (16H, m), 1.71-1.78 (2H. quint., J =6.8Hz), 4.24 (3H, s), 4.31 (2H, t, J =6.8Hz), 7.07 (1H, s). 23 'HNMRCCDCIj) δ 2.49 (3H. s), 4.19 (3H. s), 7.14 (1H, s). 57 Ή NMR (CDCI3) δ 0.88 (3H, t, t/=6.8Hz), 1.28-1.35 (10H, m), 1.60 (2H, m), 3.40 (2H, m), 4.21 (3H, s), 6.03 (1H, br-s), 6.73 (1H, s). 58 Ή NMR (CDCI3) δ 0.88 (3H, t, ^7.3Hz), 1.20-1.35 (20H, m), 3.38-3.43 (2H, m), 4.22 (3H, s), 5.99 (1H, br-s), 6.73 (1H, s). 59 Ή NMR (CDCI3) δ 0.88 (3H, t. ^7.3Hz), 1.23 (3H, d, ^6.3Hz), 1.24-1.35 (8H. m), 1.49-1.53 (2H, m), 4.09-4.14 (1H, m), 4.21 (3H, s), 5.77 (1H, br-d, Jt8.3Hz), 6.72 (1H, s). 60 Ή NMR (CDCI3) (5 0.85-0.92 (3H, m), 1.20-1.30 (10H, m), 1.55-1.70 (2H, m), 3.08 (3H, s), 3.37 (1H, t, 〇fc7.3Hz), 3.52 (1H, t, ^7.3Hz), 3.99 (3H x 1/2, s), 4.02 (3H x 1/2, s), 6.54 (1H x 1/2, s), 6.59 (1H x 1/2, s). 61 Ή NMR (CDCI3) δ 4.20 (3H, s), 5.16-5.26 (2H, m), 5.84-5.90 (1H, m), 6.93 (1H, s). 32 200916444 【表13】 化合物編號 物性値 64 'HNMRCCDCIs) &lt;5 4.18 (3H, s), 5.80 (1H,s), 6.69-7.40 (10H,m). m.p.: 119-121¾ 66 Ή NMR (CDCI3) δ 2.45 (3H, s), 4.17 (3H, s), 6.20 (1H, s), 7.15-7.17 (2H. m), 7.38-7.47 (3H, m). 69 Ή NMR (CDCI3) (5 1.23 (6H, d, ^6.8Hz), 3.04 (1H. m), 4.16 (3H, s), 6.35 (1H. s), 7.15 (2H, m). 7.42-7.46 (3H, m). m.p.: 84-88°C 70 'H NMR (CDCI3) 6 3.78 (3H, s), 4.15 (3H, s\ 6.61 (1H, s), 7.21 (2H, m), 7.44 (3H, m). 71 1H NMR (CDCI3) 6 4.18 (3H, s), 6.76 (1H, s), 7.05 (2H, m), Ί.22-1.52 (8H, m). 73 Ή NMR (CDCI3) δ 4.07 (3H, s), 5.73 (1H, s), 7.25 (2Hr m), 7.44-7.60 (5H, m), 7.69 (1H, m), 8.01 (2H, m). m.p.: 149.6-151.2°C 82 Ή NMR (CDCI3) δ 4.14 (6H, s), 7.41 (1H, d, ^7.8Hz), 7.60 (1H, t, J=7.8Hz), 7.70-7.72 (1H, m), 7.79 (1H, d,占6.3Hz). 83 Ή NMR (CDCI3) 6 1.0K3H, d, ι/=6·8Ηζ), 1.03(3H, d, J=T.3Hz), 2.32(1 H, m), 4.20OH, s), 4.62(1 H, dd, ^8.3Hz, 4.9Hz), 7.03(1 H, s), 7.19(1 H, d, jt8.3Hz). m.p: 143.2-145.6°C 93 Ή NMR (CDCI3) 5〇.98(3H ,d,夕7.3Hz), 1.01(3H, d, Α6.8Ηζ),2.2X1H, m), 3.80(3H, s), 4.20(3H, s), 4.69(1 H, dd, ufc8.3Hz, 4.9Hz), 6.53(1 H, d, ^8.3Hz), 6.86(1 H, s). m.p.: 60.4~62.0°C 94 Ή-NMR (CDCI3, ppm): 0.98 (3H, d, .A6.83HZ), 1.01 (3H, d, J=6.83Hz) 2.27 (1H, m), 3.80 (3H, s), 4.20 (3H, s), 4.69 (1H, dd, ^4.88Hzt 8.78Hz), 6.56 (1H, d, ut8.29Hz), 6.87 (1H, s) m.p.: 58.8-61.2°C 96 Ή-NMR (CDCI3, ppm): 1.32 (3H, t, cA7.32Hz), 1.52 (3H, d, ιΛ7.32Ηζ), 4.20 (3H, s), 4.26 (2H,q, ut7.32Hz), 6.74 (1H, d, J=6.83Hz), 6.85 (1H, s) m.p.:68.8-70.8°C 103 Ή NMR (CDCI3) δ 3.52 (3H, s), 4.23 (3H, s), 5.75 (1H, s), 7.30-7.33 (2H, m). 7.46-7.52 (3H, m). 33 200916444 【表14】Compound No. R 1 R 2 R3 R8 R 9 R 1 0 178 Me CF3 HHH cf3 \ Me 179 Me CF3 HHH CN 180 Me CF3 HHH &gt;&gt; 181 Me CF3 HHH Me 182 Me CF3 HH COOMe Ph 183 Me CF3 HH COOPh Ph 184 Me CF3 HH S02Me Ph 185 Me CF3 HH S02Ph Ph 186 Me CF3 uu GONHMe Ph 187 Me CF3 H Ph CONHPh H 188 Me CF3 HHHX) 189 Me CF3 HHH XTMe 190 Me CF3 H XrMe HH 191 Me C'F3 jCT 192 Me CF3 H XT HH 30 200916444 [Table 11] Compound No. R 1 R 2 R3 R8 R 9 R 1 0 193 Me CF3 HHH Bz 194 Me CF3 HH Ph Ph 195 Me CF3 HHH CONHPh 196 Me CF3 H Me H f3c 197 Me CF3 HHH FsQ W lie 0 198 Me CF3 HHH ^aCN 199 Me CF3 HH S02Ph f3c w fie 0 200 Me CF3 HH Me Me 201 Me CF3 H Bz Bz Ph 202 Me CF3 H Ac Ac Ph 203 Me CF3 l_j u -G(C02Me)=CH -CH=CH-204 Me CF3 HHH 3 205 Me CF3 HHH 206 Me CF3 HH h 207 Me CF3 HH - (CH2)5- 31 200916444 [Table 12] Compound No. 値3 Ή NMR (CDCI3) δ 0.89 (3Η, t, ^6.8Ηζ), 1.24-1.45 (10H, m), 1.71-1.78 (2H, m), 4.23 (3H, s), 4.31 (2H, t, 〇ί= 6.8Ηζ), 7.07 (1H, s). 4 Ή NMR (CDCI3) &lt;5 1.29-1.49 (4H.m), 1.52-1.62 (2H, m), 1.76-1.80 (2H.m), 1.91-1.96 (2H, m), 4.23 (3H, s), 4.97-5.04 (1H. m), 7.07 (1H, s). 7 'HNMR (CDCg &lt;5 4.28 (3H, s), 7.17-7.24 (2H, m), 7.29-7.32 (2H, m), 7.43-7.48 (2H, m). 8 Ή NMR (CDCI3) δ 4.01 (3H, s), 4.25 (3H, s), 5.35 (2H, s), 6.56 (1H, s), 7.08 (1H, s)_ mp: 75.2-77.6°C 9 Ή NMR (CDCI3) δ 2.48 (3H, s), 4.29 (3H, s), 6.23 (1H, s), 7.35 ( 1H, s). mp: 31-33°C 10 Ή NMR (CDCI3) 6 4.29 (3H, s), 7.17 (1H, d, 〇/=7.3Ηζ), 7.32-7.35 (2H, m), 7.86- 7.91 (1H,m), 8.48(1 H,m) mp: 58.4-60.8°C 11 1H NMR (CDCI3) δ 4.30 (3H, s), 7.37-7.40 (2H, m), 8.82 (2H, d, l/=4.9Hz) 22 Ή NMR (CDC!3) &lt;5 0.88 (3H, t, u/=6.8Hz), 1.26-1.41 (2H, septet, J =7.3Hz), 1.50-1.60 (16H, m), 1.71-1.78 (2H. quint., J = 6.8 Hz), 4.24 (3H, s), 4.31 (2H, t, J = 6.8 Hz), 7.07 (1H, s). 23 'HNMRCCDCIj) δ 2.49 (3H. s), 4.19 (3H. s), 7.14 (1H, s). 57 Ή NMR (CDCI3) δ 0.88 (3H, t, t/=6.8Hz), 1.28-1.35 (10H, m), 1.60 (2H, m), 3.40 (2H, m), 4.21 (3H, s), 6.03 (1H, br-s), 6.73 (1H, s). 58 Ή NMR (CDCI3) δ 0.88 (3H, t, ^7.3Hz) , 1.20-1.35 (20H, m), 3.38-3.43 (2H, m), 4.22 (3H, s), 5.99 (1H, br-s), 6.73 (1H, s). 59 Ή NMR (CDCI3) δ 0.88 (3H, t. ^7.3Hz), 1.23 (3H, d, ^6.3Hz), 1.24-1.35 (8H. m), 1.49-1.53 (2H, m), 4.09-4.14 (1H, m), 4.21 ( 3H, s), 5.77 (1H, br-d, Jt8.3Hz), 6.72 (1H, s). 60 Ή NMR (CDCI3) (5 0.85-0.92 (3H, m), 1.20-1.30 (10H, m) , 1.55-1.70 (2H, m), 3.08 (3H, s), 3.37 (1H, t, 〇fc7.3Hz), 3.52 (1H, t, ^7.3Hz), 3.99 (3H x 1/2, s) , 4.02 (3H x 1/2, s), 6.54 (1H x 1/2, s), 6.59 (1H x 1/2, s). 61 Ή NMR (CDCI3) δ 4.20 (3H, s), 5.16- 5.26 (2H, m), 5.84-5.90 (1H, m), 6.93 (1H, s). 32 200916444 [Table 13] Compound number physical properties '64 'HNMRCCDCIs) &lt;5 4.18 (3H, s), 5.80 (1H , s), 6.69-7.40 (10H, m). mp: 119-1213⁄4 66 Ή NMR (CDCI3) δ 2.45 (3H, s), 4.17 (3H, s), 6.20 (1H, s), 7.15-7.17 ( 2H. m), 7.38-7.47 (3H, m). 69 Ή NMR (CDCI3) (5 1.23 (6H, d, ^6.8Hz), 3.04 (1H. m), 4.16 (3H, s), 6.35 (1H .s) , 7.15 (2H, m). 7.42-7.46 (3H, m). mp: 84-88°C 70 'H NMR (CDCI3) 6 3.78 (3H, s), 4.15 (3H, s\ 6.61 (1H, s ), 7.21 (2H, m), 7.44 (3H, m). 71 1H NMR (CDCI3) 6 4.18 (3H, s), 6.76 (1H, s), 7.05 (2H, m), Ί.22-1.52 ( 8H, m). 73 Ή NMR (CDCI3) δ 4.07 (3H, s), 5.73 (1H, s), 7.25 (2Hr m), 7.44-7.60 (5H, m), 7.69 (1H, m), 8.01 ( 2H, m). mp: 149.6-151.2°C 82 Ή NMR (CDCI3) δ 4.14 (6H, s), 7.41 (1H, d, ^7.8Hz), 7.60 (1H, t, J=7.8Hz), 7.70 -7.72 (1H, m), 7.79 (1H, d, 6.3 Hz). 83 Ή NMR (CDCI3) 6 1.0K3H, d, ι/=6·8Ηζ), 1.03(3H, d, J=T.3Hz ), 2.32(1 H, m), 4.20OH, s), 4.62 (1 H, dd, ^8.3Hz, 4.9Hz), 7.03(1 H, s), 7.19(1 H, d, jt8.3Hz) Mp: 143.2-145.6°C 93 Ή NMR (CDCI3) 5〇.98(3H,d, 夕7.3Hz), 1.01(3H, d, Α6.8Ηζ), 2.2X1H, m), 3.80(3H, s ), 4.20(3H, s), 4.69(1 H, dd, ufc8.3Hz, 4.9Hz), 6.53(1 H, d, ^8.3Hz), 6.86(1 H, s). mp: 60.4~62.0° C 94 Ή-NMR (CDCI3, ppm): 0.98 (3H, d, .A6.83HZ), 1.01 (3H, d, J = 6.83Hz) 2.27 (1H, m), 3.80 (3H, s), 4.20 ( 3H, s), 4.69 (1H, dd, ^4.88Hzt 8.78Hz), 6.56 (1H, d, ut8.29Hz), 6.87 (1H, s) mp: 58.8-61.2°C 96 Ή-NMR (CDCI3, ppm): 1.32 (3H, t, cA7.32Hz), 1.52 (3H, d , ιΛ7.32Ηζ), 4.20 (3H, s), 4.26 (2H,q, ut7.32Hz), 6.74 (1H, d, J=6.83Hz), 6.85 (1H, s) mp:68.8-70.8°C 103 NMR NMR (CDCI3) δ 3.52 (3H, s), 4.23 (3H, s), 5.75 (1H, s), 7.30-7.33 (2H, m). 7.46-7.52 (3H, m). 33 200916444 [Table 14 】

化合物編號 物性値 104 Ή NMR (CDCI3) δ 4.15 (3Η, s), 6.50 (1H, s), 7.16 (2H, d. c^6.8Hz), 7.36-7.43 (5H, m), 7.68 (2H. d, ^6.8Η2). 105 Ή NMR (CDCI3) 6 2.37 (3H, s), 4.13 (3H, s), 6.54 (1H, s), 7.16-7.20 (4H, m), 7.32-7.43 (3H, m), 7.64 (2H. d, ^8.3Hz). 106 Ή NMR (CDCI3) 6 1.16 (dH, 6.3), 4.14 (sH), 4.95-5.02 (mH. m), 6.66 (sH). 7.21-7.23 (mH, m), 7.40-7.47 (mH. m). 107 Ή NMR (CDCI3) δ 4.07 (3H, s), 5.17 (2H, s), 6.57 (1H, s), 7.15-7.21 (3H, m), 7.32-7.45 (7H, m). 108 Ή NMR (CDCI3) δ 4.17 (3H, s), 4.55 (2H, q. Vwf=8.3Hz), 6.64 (1H, s), 7.22-7.25 (2H, m), 7.41-7.50 (3H, m). 109 'H NMR (CDCI3) δ 4.19 (3Hr s), 6.71 (1H, s)( 7.31-7.34 (4H, m), 7.45-7.52 (3H? m). 110 Ή NMR (CDC!3) δ 2.32 (3H, s), 4.18 (3H, s), 6.76 (1H, s), 6.91 (2H, d, ^8.3Hz), 7.15 (2H, d, ui=8.3Hz), 7.33-7.36 (2H. m). 7.44-7.52 (3H, m). 111 1H NMR (CDCI3) 5 4.09 (3H, s), 5.76 (1H, s), 7.22 (2H, d, jf=7.8Hz), 7.44-7.56 (5H, m), 7.94 (2H, d, ^=7.8Hz). 112 Ή NMR (CDCI3) δ 4.14 (3H, s), 4.68 (2H, br-s), 6.23 (1H, br-s), 6.34-6.36 (1H, m), 7.19 (1H, s), 7.54 (1H, s), 8.04 (1H, br-s), 8.12 (1H, br-s), 8.20 (1H, br-s). 113 1H NMR (CDCI3) δ 2.26 (3H, s), 4.09 (3H, s), 5.44 (1H, s), 7.16 (1H, d, J=7.3Hz), 7.29-7.72 (6H. m). 8.14 (2H, d, t/=7.3Hz). Λ Λ r* Λ Λ Λ mp; οο.ο一u 114 Ή NMR (CDCI3) δ 2.20 (6H, s), 4.12 (3H, s), 5.32 (1H, s), 7.17 (2H, d, J=7.8Hz), 7.33 (1H, t, J=7.8Hz), 7.60 (2H, t. J=7.8Hz), 7.70-7.74 (1H. m), 7.26 (2H, d, J =7.8Hz). mp; 138.0-140.0°C 115 1H NMR (CDCI3) δ 4.04 (3H, s), 5.83 (1H, s), 7.37 (1H, s), 7.43-7.49 (2H, m), 7.58 (2H, t, l/=7.8Hz), 7.69-7.72 (2H, m), 8.10-8.12 (2H, m). 116 Ή NMR (CDCI3) δ 4.08 (3H, s), 5.86 (1H, s), 7.37 (2H, d, l/=7.8Hz), 7.59 (2H, t, J =7.8Hz), 7.71-7.74 (3H. m), 7.98 (2H, d, J=7.8Hz). mp; 143.4-146.0°C 117 Ή NMR (CDCI3) δ 4.08 (3H, s), 5.92 (1H, s), 7.36 (2H, d, ./=7.8Ηζ), 7.59 (2H. t, J =7.8Hz), 7.72-7.77 (3H, m), 7.95 (2H, d, 〇/=7.8Hz). mp; 178.8-181.2°C 34 200916444 【表15】Compound number 値 104 Ή NMR (CDCI3) δ 4.15 (3Η, s), 6.50 (1H, s), 7.16 (2H, d. c^6.8Hz), 7.36-7.43 (5H, m), 7.68 (2H. d, ^6.8Η2). 105 Ή NMR (CDCI3) 6 2.37 (3H, s), 4.13 (3H, s), 6.54 (1H, s), 7.16-7.20 (4H, m), 7.32-7.43 (3H, m), 7.64 (2H.d, ^8.3Hz). 106 Ή NMR (CDCI3) 6 1.16 (dH, 6.3), 4.14 (sH), 4.95-5.02 (mH. m), 6.66 (sH). 7.21-7.23 (mH, m), 7.40-7.47 (mH.m). 107 Ή NMR (CDCI3) δ 4.07 (3H, s), 5.17 (2H, s), 6.57 (1H, s), 7.15-7.21 (3H, m ), 7.32-7.45 (7H, m). 108 Ή NMR (CDCI3) δ 4.17 (3H, s), 4.55 (2H, q. Vwf=8.3Hz), 6.64 (1H, s), 7.22-7.25 (2H, m), 7.41-7.50 (3H, m). 109 'H NMR (CDCI3) δ 4.19 (3Hr s), 6.71 (1H, s) ( 7.31-7.34 (4H, m), 7.45-7.52 (3H? m) 110 Ή NMR (CDC!3) δ 2.32 (3H, s), 4.18 (3H, s), 6.76 (1H, s), 6.91 (2H, d, ^8.3Hz), 7.15 (2H, d, ui= 8.3Hz), 7.33-7.36 (2H.m). 7.44-7.52 (3H, m). 111 1H NMR (CDCI3) 5 4.09 (3H, s), 5.76 (1H, s), 7.22 (2H, d, jf =7.8Hz), 7.44-7.56 (5H, m), 7.94 (2H, d, ^=7.8Hz). 112 Ή NMR (CDCI3) δ 4.14 (3H, s), 4.68 (2H , br-s), 6.23 (1H, br-s), 6.34-6.36 (1H, m), 7.19 (1H, s), 7.54 (1H, s), 8.04 (1H, br-s), 8.12 (1H , br-s), 8.20 (1H, br-s). 113 1H NMR (CDCI3) δ 2.26 (3H, s), 4.09 (3H, s), 5.44 (1H, s), 7.16 (1H, d, J =7.3Hz), 7.29-7.72 (6H.m). 8.14 (2H, d, t/=7.3Hz). Λ Λ r* Λ Λ Λ mp; οο.ο a u 114 Ή NMR (CDCI3) δ 2.20 ( 6H, s), 4.12 (3H, s), 5.32 (1H, s), 7.17 (2H, d, J=7.8Hz), 7.33 (1H, t, J=7.8Hz), 7.60 (2H, t. J =7.8Hz), 7.70-7.74 (1H.m), 7.26 (2H, d, J = 7.8Hz). mp; 138.0-140.0°C 115 1H NMR (CDCI3) δ 4.04 (3H, s), 5.83 (1H , s), 7.37 (1H, s), 7.43-7.49 (2H, m), 7.58 (2H, t, l/=7.8Hz), 7.69-7.72 (2H, m), 8.10-8.12 (2H, m) 116 Ή NMR (CDCI3) δ 4.08 (3H, s), 5.86 (1H, s), 7.37 (2H, d, l/=7.8Hz), 7.59 (2H, t, J = 7.8Hz), 7.71-7.74 (3H.m), 7.98 (2H, d, J=7.8Hz). mp; 143.4-146.0°C 117 Ή NMR (CDCI3) δ 4.08 (3H, s), 5.92 (1H, s), 7.36 (2H, d, ./=7.8Ηζ), 7.59 (2H.t, J = 7.8Hz), 7.72-7.77 (3H, m), 7.95 (2H, d, 〇/=7.8Hz). mp; 178.8-181.2°C 34 200916444 [Table 15]

化合物編號 物性値 118 1H NMR (CDCI3) δ 2.52 (3Η, s), 4.07 (3H, s), 5.89 (1H, s), 7.10-7.13 (2H, m), 7.25-7.28 (2H, m), 7.56 (2H, t, J=l.8Hz), 7.69 (1H, t, J =7.8Hz), 8.01 (2H, d, J =7.8Hz). mp; 180.4-181.2°C 119 Ή NMR (CDCI3) δ 3.91 (3H, s), 4.08 (3H, s), 5.72 (1H, s), 7.01 (2H. d, .;=7.8Ηζ), 7.22 (2H, d, 7.43-7.51 (3H, m), 7.96 (2H, d. J=T.8Hz). mp; 149.6-155.2°C 120 1H NMR (CDCI3) δ 4.09 (3H, s), 5.78 (1H, s), 7.22-7.25 (2H, m), 7.48 (2H, t, J =7.8Hz), 7.54 (1H, t, J=1.8Hz), 7.57 (2H, d, J=7.3Hz), 8.12 (2H, d, J=7.3Hz). mp; 164.4-195.2°C 121 Ή NMR (CDCI3) δ 0.99 (3H, t, l/=7.8Hz)I 1.0-1.56 (H. m), 1.92-1.95 (2H, m). 3.74-3.78 (2H, m), 4.22 (3H. s), 5.63 (1H, s), 7.33 (2H, dd. ,/=1.5, 7.8Hz), 7.47-7.52 (3H, m). mp; 108.8-110.4°C 122 Ή NMR (CDCI3) S 4.05 (3H, s), 5.92 (1H, s), 7.52 (1H, dd. J=A.8, 7.8Hz). 7.59 (2H, t, J=7.8Hz), 7.74 (1H, t, JsISHz), 8.05 (2H, d, JsT.BHz), 8.17 (1H, dd, J =1.5, 7.8Hz), 8.49 (1H, dd, J=1.5, 4.8Hz). mp; 119.2-120.0¾ 123 1H NMR (CDCI3) δ 0.95 (3H, t, J=7.3Hz), 1.24-1.40 (3H, m), 1.72-1.77 (3Hr m), 3.77 (3H, s), 3.92-3.96 (2H, m), 6.56 (1H, s), 7.52-7.56 (2H, m), 7.65 (1H, t, J _irtll \ -1 &quot;Ί Λ /ΛΙ 1 1 1 ! —-i f- -1 rn 1 \ -/.on乙人 /./h、乙π, αα, l/— i_o,八0门ζλ 124 Ή NMR (CDCI3) &lt;5 3.64 (3Η, s), 5.15 (2H, s), 6.52 (1H, s), 7.18-7.35 (5H, m), 7.48-7.66 (5H, m). mp; 110.4-111.6°C 125 Ή NMR (CDCI3) c5 4.26 (3H, s), 5.05 (2H, s), 5.30 (1H, s), 6.46 (2H, dd, ./=1.5, 7.8Hz), 7.22 (2H, t, J=7.8Hz), 7.36-7.50 (6H, m). mp; 146,0-147.6°C 126 1H NMR (CDCI3) δ 0.83-0.90 (3H, m), 1.22-1.31 (6H, m), 1.74-1.78 (2H, m), 3.78 (3H, s), 3.91-3.95 (2H. m). 6.56 (1H, s). 7.52-7.55 (3H; m), 7.65-7.76 (2H: m). 127 Ή NMR (CDCQ &lt;5 3.53 (3H, s), 3.98 (3H, s), 6.04 (1H, s). 7.09 (1H, dd, J=5,3. 7.3Hz), 7.56 (2H, t, l/=7.8Hz), 7.67-7.71 (1H, m), 7.91 (1H, dd, J=2.0, 7.8Hz), 7.99 (2H, dd, J=1.5, 7.3Hz), 8.21 (1H, dd, i/=1.5, 5.3Hz). mp; 135.6-138.8°C 35 200916444 【表16】 化合物編號 物性値 128 1H NMR (CDCI3) δ 3.86 (3Η, s), 4.07 (3H, s), 5.82 (1H, s), 6.94 (2H, dd, J=2.0, 6.8Hz), 7.12 (2H, dd, J=2.0, 6.8Hz), 7.58 (2H, t, v/=7.8Hz), 7.72 (1H, t, ,/=7.8Hz), 8.01 (2H, d, ι;=7.8Ηζ). 129 Ή NMR (CDCI3) δ 0.88 (3H, t, cy=7.3Hz), 1.27-1.50 (10H, m), 1.93-1.97 (2H, m), 3.72-3.76 (2H, m), 4.22 (3H, s), 5.63 (1H, s), 7.30-7.32 (2H, m), 7.46-7.52 (3H, m). mp; 102.0-103.2°C 130 Ή NMR (CDCQ &lt;5 0.87 (3H, t, J=6.8Hz), 0.97 (3H, t, l/=7.3Hz), 1.25-1.29 (10H, m), 1.46-1.52 (2H, m), 1.67-1.69 (2H, m), 1.80-1.85 (2H, m), 3.49 (2H, t, J=7.8Hz), 3.82 (2H, t, t/=7.8Hz), 4.05 (3H, s), 6.76 (1H, s). mp; 59.8-61.0°C 131 1H NMR (CDCI3) δ 0.88 (3H, t, ,/^β.βΗζ), 1.24-1.34 (6H, m), 1.56-1.62 (2H, m), 3.40 (2H, dd, J=6.3, 6.8Hz), 4.22 (3H, s), 5.99 (1H, br-s), 6.73 (1H, s). 132 Ή NMR (CDCI3) δ 0.88 (3H, t, J=6.8Hz), 1.24-1.34 (14H, m), 1.56-1.63 (2H, m), 3.38-3.43 (2H, m), 4.22 (1H, s), 5.99 (1H, br~s), 6.73 (1H, s). 133 Ή NMR (CDCI3) δ 0.89 (3H, t, l/=7.3Hz), 1.24-1.36 (8H, m), 1.54-1.62 (2H, m), 3.38-3.43 (2H, m), 4.21 (3H, s), 6.00 (1H, br-s), 6.73 (1H, s). 134 Ή NMR (CDCI3) δ 0.88 (3H, t, J=7.3Hz), 1.24-1.36 (12H, m), 1.56-1.63 (2H, m), 3.38-3.43 (2H, m), 4.21 (3H, s), 6.00 (1H, br-s), 6.73 (1H, s). 135 Ή NMR (CDCI3) δ 4.09 (3H, s), 5.99 (1H, s), 7.44 (2H, dd, J=2.0, 6.8Hz), 7.59 (2H, t, J=7.8Hz), 7.72-7.74 (1H, m), 7.95 (2H, dd, ./=1.5, 7.8Hz), 8.32 (2H, dd, J =2.0, 6.8Hz). mp; 155.5-156.6°C 136 1H NMR (CDCI3) δ 4.07 (3H, s), 5.83 (1H, s), 7.13-7.24 (4H, m), 7.59 (2H, t, J =7.8Hz), 7.72 (1H, t, J=7.8Hz), 7.99 (2H, d, l/=7.8Hz). mp; 116-116.8°C 137 1H-NMR (CDCI3, ppm): 0.98 (3H, d. ^6.83Hz), 1.01 (3H, d, ./:6.83Hz) 1.32 (3H, t, jt6.83Hz)f 2.28 (1H, m), 4.20 (3H, s), 4.26 (2H, m), 4.67 (1H, m), 6.60 (1H, d, ut8.29Hz). 6.87 (1H, s) m.p_:油狀物 138 Ή-NMR (CDCI3. ppm): 3.78 (3H, s), 4.17 (3H, s), 5.67 (1H, d, υ&lt;=6.83Ηζ), 6.90 (1H,s), 7.11 (1H, d, 〇t6.43Hz), 7.34-7.42 (5H, m) m.p.:半固體 36 200916444 【表17】Compound No. 値118 1H NMR (CDCI3) δ 2.52 (3Η, s), 4.07 (3H, s), 5.89 (1H, s), 7.10-7.13 (2H, m), 7.25-7.28 (2H, m), 7.56 (2H, t, J=l.8Hz), 7.69 (1H, t, J = 7.8Hz), 8.01 (2H, d, J = 7.8Hz). mp; 180.4-181.2°C 119 Ή NMR (CDCI3) δ 3.91 (3H, s), 4.08 (3H, s), 5.72 (1H, s), 7.01 (2H.d, .;=7.8Ηζ), 7.22 (2H, d, 7.43-7.51 (3H, m), 7.96 (2H, d. J=T.8Hz). mp; 149.6-155.2°C 120 1H NMR (CDCI3) δ 4.09 (3H, s), 5.78 (1H, s), 7.22-7.25 (2H, m), 7.48 (2H, t, J = 7.8 Hz), 7.54 (1H, t, J = 1.8 Hz), 7.57 (2H, d, J = 7.3 Hz), 8.12 (2H, d, J = 7.3 Hz). mp; 164.4-195.2°C 121 Ή NMR (CDCI3) δ 0.99 (3H, t, l/=7.8Hz) I 1.0-1.56 (H. m), 1.92-1.95 (2H, m). 3.74-3.78 (2H, m ), 4.22 (3H. s), 5.63 (1H, s), 7.33 (2H, dd., /=1.5, 7.8Hz), 7.47-7.52 (3H, m). mp; 108.8-110.4°C 122 Ή NMR (CDCI3) S 4.05 (3H, s), 5.92 (1H, s), 7.52 (1H, dd. J=A.8, 7.8Hz). 7.59 (2H, t, J=7.8Hz), 7.74 (1H, t, JsISHz), 8.05 (2H, d, JsT.BHz), 8.17 (1H, dd, J = 1.5, 7.8Hz), 8.49 (1H, dd, J=1.5, 4.8Hz). mp; 119.2-120.03⁄4 123 1H N MR (CDCI3) δ 0.95 (3H, t, J=7.3Hz), 1.24-1.40 (3H, m), 1.72-1.77 (3Hr m), 3.77 (3H, s), 3.92-3.96 (2H, m), 6.56 (1H, s), 7.52-7.56 (2H, m), 7.65 (1H, t, J _irtll \ -1 &quot;Ί Λ /ΛΙ 1 1 1 ! ---i f- -1 rn 1 \ -/. On B/./h, B π, αα, l/- i_o, 八门ζλ 124 Ή NMR (CDCI3) &lt;5 3.64 (3Η, s), 5.15 (2H, s), 6.52 (1H, s ), 7.18-7.35 (5H, m), 7.48-7.66 (5H, m). mp; 110.4-111.6°C 125 Ή NMR (CDCI3) c5 4.26 (3H, s), 5.05 (2H, s), 5.30 ( 1H, s), 6.46 (2H, dd, ./=1.5, 7.8Hz), 7.22 (2H, t, J=7.8Hz), 7.36-7.50 (6H, m). mp; 146,0-147.6°C 126 1H NMR (CDCI3) δ 0.83-0.90 (3H, m), 1.22-1.31 (6H, m), 1.74-1.78 (2H, m), 3.78 (3H, s), 3.91-3.95 (2H. m). 6.56 (1H, s). 7.52-7.55 (3H; m), 7.65-7.76 (2H: m). 127 Ή NMR (CDCQ &lt;5 3.53 (3H, s), 3.98 (3H, s), 6.04 (1H , s). 7.09 (1H, dd, J=5, 3. 7.3Hz), 7.56 (2H, t, l/=7.8Hz), 7.67-7.71 (1H, m), 7.91 (1H, dd, J= 2.0, 7.8 Hz), 7.99 (2H, dd, J=1.5, 7.3 Hz), 8.21 (1H, dd, i/=1.5, 5.3 Hz). mp; 135.6-138.8°C 35 200916444 [Table 16] Compound numberPhysical properties 1 128 1H NMR (CDCI3) δ 3.86 (3Η, s), 4.07 (3H, s), 5.82 (1H, s), 6.94 (2H, dd, J=2.0, 6.8Hz), 7.12 (2H, dd, J=2.0, 6.8Hz), 7.58 (2H, t, v/=7.8Hz), 7.72 (1H, t, ,/=7.8Hz), 8.01 (2H, d, ι;=7.8Ηζ). 129 Ή NMR (CDCI3) δ 0.88 (3H, t, cy=7.3Hz), 1.27-1.50 (10H, m), 1.93-1.97 (2H, m), 3.72-3.76 (2H, m), 4.22 (3H, s), 5.63 (1H, s), 7.30-7.32 (2H, m), 7.46-7.52 (3H, m). mp; 102.0-103.2°C 130 Ή NMR (CDCQ &lt;5 0.87 (3H, t, J=6.8Hz) ), 0.97 (3H, t, l/=7.3Hz), 1.25-1.29 (10H, m), 1.46-1.52 (2H, m), 1.67-1.69 (2H, m), 1.80-1.85 (2H, m) , 3.49 (2H, t, J=7.8Hz), 3.82 (2H, t, t/=7.8Hz), 4.05 (3H, s), 6.76 (1H, s). mp; 59.8-61.0°C 131 1H NMR (CDCI3) δ 0.88 (3H, t, , /^β.βΗζ), 1.24-1.34 (6H, m), 1.56-1.62 (2H, m), 3.40 (2H, dd, J=6.3, 6.8Hz), 4.22 (3H, s), 5.99 (1H, br-s), 6.73 (1H, s). 132 Ή NMR (CDCI3) δ 0.88 (3H, t, J=6.8Hz), 1.24-1.34 (14H, m) , 1.56-1.63 (2H, m), 3.38-3.43 (2H, m), 4.22 (1H, s), 5.99 (1H, br~s), 6.73 (1H, s). 133 Ή NMR (CDCI3) δ 0.89 (3H, t, l/=7.3Hz), 1.24-1.36 (8H, m), 1.54-1.62 (2H, m), 3.38-3.43 (2H, m), 4.21 (3H, s), 6.00 (1H, br-s), 6.73 (1H, s). 134 Ή NMR (CDCI3) δ 0.88 (3H, t, J=7.3Hz), 1.24-1.36 (12H, m), 1.56-1.63 (2H, m), 3.38-3.43 (2H, m), 4.21 (3H, s), 6.00 (1H, br-s), 6.73 (1H, s). 135 Ή NMR (CDCI3) δ 4.09 (3H, s), 5.99 (1H, s), 7.44 (2H, dd, J=2.0, 6.8Hz), 7.59 (2H, t, J=7.8Hz), 7.72-7.74 (1H, m), 7.95 (2H, dd, ./=1.5, 7.8Hz), 8.32 (2H, dd, J =2.0, 6.8Hz). mp; 155.5-156.6°C 136 1H NMR (CDCI3) δ 4.07 (3H, s), 5.83 (1H, s), 7.13-7.24 (4H, m), 7.59 (2H, t, J = 7.8 Hz), 7.72 (1H, t, J=7.8Hz), 7.99 (2H, d, l/=7.8Hz). mp; 116-116.8°C 137 1H-NMR (CDCI3, ppm): 0.98 (3H, d ^6.83Hz), 1.01 (3H, d, ./:6.83Hz) 1.32 (3H, t, jt6.83Hz)f 2.28 (1H, m), 4.20 (3H, s), 4.26 (2H, m), 4.67 (1H, m), 6.60 (1H, d, ut8.29Hz). 6.87 (1H, s) m.p_: oil 138 Ή-NMR (CDCI3. ppm): 3.78 (3H, s), 4.17 ( 3H, s), 5.67 (1H, d, υ&lt;=6.83Ηζ), 6.90 (1H, s), 7.11 (1H, d, 〇t6.43Hz), 7.34-7.42 (5H, m) mp: semi-solid 36 200916444 [Table 17]

化合物編號 物性値 139 Ή-NMR (CDCI3i ppm): 1.67 (6H, s). 3.80 (3H, s), 4.19 (3H, s). 6.71 (1H. br-s), 6.80 (1H, s) m.p. 112.8-114.8°C 140 Ή-NMR (CDCI3. ppm): 1.27-1.34 (6H, m), 2.61 (2H. m), 4.18 (2H. m). 4.22 (3H, s), 4.49 (1H. m). 6.78 (1H, s), 7.05 (1H, d, J=8.29Hz) m.p_:油狀物 141 Ή-NMR (CDCI3 ppm): 2.42 (3H, s), 4.06 (3H, s), 5.79 (1H, s). 7.11 (2H, dd, 41.95Hz, 6.34Hz), 7.25 (2H, d, Jt8.29Hz), 7.56 (2H, m), 7.70 (1H,m), 8.01 (2H, m) m.p.: 126.4-129.6°C 142 Ή-NMR (CDCI3. ppm): 4.07 (3H, s), 5.90 (1H. s), 7.17 (2H. m). 7.43 (2H, m), 7.57 (2H, m). 7.71 (1H,m), 7.97 (2H. m) m.p.:124.8-127.6°C 143 Η-NMR (CDCI3. ppm): 0.88 (3H, t, J=7.32Hz), 1.21-1.30 (10H, m), 1.76 (2H. t, 〇fc7.32Hz). 3.78 (3H, s), 3.93 (2H, t, ^7.81 Hz). 6.56 (1H, s), 7.54 (2H, m), 7.67 (1H, m), 7.74 (2H, m) m.p.: 66.4-69.6°C 144 Ή NMR (CDCI3) δ 3.43 (3H, s), 4.10 (3H, s), 6.20 (1H, s), 6.30 (1H, s), 8.13 (1Hr s). 145 Ή NMR (DMSO-4) δ 3.17 (3H, s), 3.93 (3H, s). 5.02 (2H, s), 7.00 (1H, s). 146 Ή NMR (CDCI3) δ 1.00-2.00 (10H, m), 4.04 (1H, m), 4.11 (3H, s), 6.63 (1H, s), 6.87 (1H, s), 8.20 (1H, s). 150 Ή NMR (CDCI3) 5 4.21 (3H, s), 6.20 (1H, br-s like), 6.89 (2H, d, l/=8.3Hz), 6.99 (2H, t, J=7.3Hz), 7.26-7.28 (1H, m). 151 NMR (CDCI3) δ 4.15 (3H, s)t 4.50 (2H, br-s like), 7.21-7.26 (2H, m), 7.35-7.40 (3H. m). 152 Ή NMR (CDCI3) 6 3.30 (3H, s). 4.24 (3H, s), 6.87-6.95 (4H, m), 7.27 (1H, t, J =7.3Hz), 7.81 (1H, br-s). 154 Ή NMR (CDCI3) δ 2.94 (4H, m), 3.86 (4H, m), 4.22 (3H. s), 6.77 (1H, s). 6.90 (1H, br-s). m_p.: 152-154〇C 156 Ή NMR (CDCI3) δ 4.19 (3H, s), 7.01 (1H, s), 7.19-7.48 (10H, m), 9.27 (1H, br-s). 182 ^ NMR (CDCI3) δ 3.84 (3Ht s)F 4.21 (3H, s), 6.93 (1Hf s)f 7.27-7.45 (5H, m)t 8.60 (1Hr br-s). 37 200916444 【表18】 化合物編號 物性値 188 Ή NMR (CDCI3) δ 4.20 (3Η, s), 6.75 (1H, d, =8.3Hz), 6.86 (1H, dd, J =6.8, 8·3Ηζ), 7.00 (1H, s), 7.20 (1H, br-s), 7.56 (1H, dd, 7=4.8, 6.8Hz), 8.17 (1H, d, J =4.8Hz). 189 Ή NMR (CDCI3) 6 2.27 (3H, s), 4.20 (3H, s), 6.18 (1H, br-s), 6.79 (2H. d, J =7.8Hz), 6.92 (1H, s), 7.06 (2H, d, u/=7.8Hz), 8.04 (1H, br-s). 190 1H NMR (CDCI3) δ 2.37 (3H, s), 4.13 (3H, s), 5.80 (2H, br-s), 7.08-7.26 (5H, m). 191 Ή NMR (CDCI3) δ 4.21 (3H, s), 6.18 (1H, br-s), 6.82 (2H, d. ./=8^2), 6.94 (1H, s), 7.23 (2H, d, J=8.8Hz), 7.82 (1H, br-s). 192 Ή NMR (CDCI3) 6 4.14 (3H( s)r 4.88 (2Hf br-s)( 7.17-7.20 (3Hf m), 7.34-7.38 (2H, m). 193 'H NMR (CDCI3) δ 4.24 (3H, s), 7.35 (1H, s), 7.47 (2H, t, J=7.3Hz), 7.49 (1H, t, J =7.3Hz), 7.95 (2H, d, J=T.3Hz), 9.90 (1H, br^s). 10.6 (1H, br-s). 194 Ή NMR (CDCI3) δ 4.23 (3H, s), 6.94 (IH, s), 7.00-7.37 (10H, m), 8.18 (1H, s). 195 Ή NMR (CDCI3) 6 4.19 (3H, s), 7.01 (1H, t, J =7.8Hz), 7.25-7.33 (3H, m). 7.43 (2H, tW=7.8Hz), 7.97 (1H, s), 8.37 (1H, s), 10.15 (1H, s). mp:224.8-226.0 196 Ή NMR (CDCI3) 6 3.55 (3H, s), 3.97 (3H, s), 4.14 (3H, s), 6.72 (1H, s), 6.87 (1H, s), 8.25 (1H, s) mp: 246.0-248.0; 197 Ή NMR (CDCI3) δ 4.24 (6H, s), 6.98 (2H, s), 8.42 (2H, s). 198 Ή NMR (CDCI3) δ 4.22 (3H, s), 6.38 (1H, s), 6.92 (2H, d, J=8.8Hz), 6.98 (1H, s), 7.56 (2H, d, J=8.8Hz), 7.86 (1H, s). 199 Ή NMR (CDCIj) δ 4.00 (3H, s), 4.08 (3H, s), 6.81 (1H, s), 7.08 (1H, s), 7.62 (2H, t, 7.75 (1H, t, u/=7.8Hz), 8.13 (2H, d, l/=7.8Hz), 9.14 (1H, br-s). 200 Ή NMR (CDCI3) δ 2.71 (6H, s), 4.22 (3H, s), 6.72 (1H, br-s). 201 1H NMR (CDCI3) δ 3.72 (3H, s), 6.65 (1H, s), 7.08-7.71 (15H, m). 202 Ή NMR (CDCIj) δ 2.05 (3H, s), 2.57 (3H, s), 3.84 (3H, s), 6.86 (1H, s), 7.01-7.03 (2H, m), 7.39-7.40 (3H, m) 203 Ή NMR (CDCI3) S 1.33 (3H, t, J=7.3Hz), 4.23 (3H, s), 4.26 (2H, q, J=7.3Hz), 6.26 (1H. dd, J=2.5, 4.0Hz), 7.00 (1H, dd, J=1.5, 4.0Hz). 7.05 (1H. s), 7.18 (1Hr dd, J =1.5, 2.5Hz), 9.60 (1H, br-s). 38 200916444 【表19】Compound No. 値 139 Ή-NMR (CDCI3i ppm): 1.67 (6H, s). 3.80 (3H, s), 4.19 (3H, s). 6.71 (1H. br-s), 6.80 (1H, s) mp 112.8-114.8°C 140 Ή-NMR (CDCI3. ppm): 1.27-1.34 (6H, m), 2.61 (2H. m), 4.18 (2H. m). 4.22 (3H, s), 4.49 (1H. m 6.78 (1H, s), 7.05 (1H, d, J = 8.29Hz) m.p_: oil 141 Ή-NMR (CDCI3 ppm): 2.42 (3H, s), 4.06 (3H, s), 5.79 (1H, s). 7.11 (2H, dd, 41.95Hz, 6.34Hz), 7.25 (2H, d, Jt8.29Hz), 7.56 (2H, m), 7.70 (1H, m), 8.01 (2H, m ) mp: 126.4-129.6 ° C 142 Ή-NMR (CDCI 3. ppm): 4.07 (3H, s), 5.90 (1H. s), 7.17 (2H. m). 7.43 (2H, m), 7.57 (2H, m). 7.71 (1H,m), 7.97 (2H.m) mp:124.8-127.6°C 143 Η-NMR (CDCI3. ppm): 0.88 (3H, t, J=7.32Hz), 1.21-1.30 (10H , m), 1.76 (2H. t, 〇fc7.32Hz). 3.78 (3H, s), 3.93 (2H, t, ^7.81 Hz). 6.56 (1H, s), 7.54 (2H, m), 7.67 ( NMR: NMR (CDCI3) δ 3.43 (3H, s) s), 8.13 (1Hr s). 145 NMR (DMSO-4) δ 3.17 (3H, s), 3.93 (3H, s). 5.02 (2H, s), 7.00 (1H, s). 146 Ή NMR (CDCI3) δ 1.00-2.00 (10H, m), 4.04 (1H, m), 4.11 (3H, s), 6.63 (1H, s), 6.87 (1H, s), 8.20 (1H , s). 150 Ή NMR (CDCI3) 5 4.21 (3H, s), 6.20 (1H, br-s like), 6.89 (2H, d, l/=8.3Hz), 6.99 (2H, t, J=7.3 Hz), 7.26-7.28 (1H, m). 151 NMR (CDCI3) δ 4.15 (3H, s)t 4.50 (2H, br-s like), 7.21-7.26 (2H, m), 7.35-7.40 (3H. m). 152 Ή NMR (CDCI3) 6 3.30 (3H, s). 4.24 (3H, s), 6.87-6.95 (4H, m), 7.27 (1H, t, J = 7.3Hz), 7.81 (1H, br - s). 154 Ή NMR (CDCI3) δ 2.94 (4H, m), 3.86 (4H, m), 4.22 (3H. s), 6.77 (1H, s). 6.90 (1H, br-s). m_p. : 152-154〇C 156 Ή NMR (CDCI3) δ 4.19 (3H, s), 7.01 (1H, s), 7.19-7.48 (10H, m), 9.27 (1H, br-s). 182 ^ NMR (CDCI3 δ 3.84 (3Ht s)F 4.21 (3H, s), 6.93 (1Hf s)f 7.27-7.45 (5H, m)t 8.60 (1Hr br-s). 37 200916444 [Table 18] Compound No. 値 188 Ή NMR (CDCI3) δ 4.20 (3Η, s), 6.75 (1H, d, =8.3Hz), 6.86 (1H, dd, J =6.8, 8·3Ηζ), 7.00 (1H, s), 7.20 (1H, br -s), 7.56 (1H, dd, 7=4.8, 6.8Hz), 8.17 (1H, d, J = 4.8Hz). 189 Ή NMR (CDCI3) 6 2. 27 (3H, s), 4.20 (3H, s), 6.18 (1H, br-s), 6.79 (2H. d, J = 7.8Hz), 6.92 (1H, s), 7.06 (2H, d, u/ = 7.8 Hz), 8.04 (1H, br-s). 190 1H NMR (CDCI3) δ 2.37 (3H, s), 4.13 (3H, s), 5.80 (2H, br-s), 7.08-7.26 (5H, m). 191 Ή NMR (CDCI3) δ 4.21 (3H, s), 6.18 (1H, br-s), 6.82 (2H, d. ./=8^2), 6.94 (1H, s), 7.23 (2H , d, J=8.8Hz), 7.82 (1H, br-s). 192 Ή NMR (CDCI3) 6 4.14 (3H( s)r 4.88 (2Hf br-s)( 7.17-7.20 (3Hf m), 7.34- 7.38 (2H, m). 193 'H NMR (CDCI3) δ 4.24 (3H, s), 7.35 (1H, s), 7.47 (2H, t, J=7.3Hz), 7.49 (1H, t, J = 7.3 Hz), 7.95 (2H, d, J=T.3Hz), 9.90 (1H, br^s). 10.6 (1H, br-s). 194 Ή NMR (CDCI3) δ 4.23 (3H, s), 6.94 ( IH, s), 7.00-7.37 (10H, m), 8.18 (1H, s). 195 Ή NMR (CDCI3) 6 4.19 (3H, s), 7.01 (1H, t, J = 7.8Hz), 7.25-7.33 (3H, m). 7.43 (2H, tW=7.8Hz), 7.97 (1H, s), 8.37 (1H, s), 10.15 (1H, s). mp:224.8-226.0 196 Ή NMR (CDCI3) 6 3.55 (3H, s), 3.97 (3H, s), 4.14 (3H, s), 6.72 (1H, s), 6.87 (1H, s), 8.25 (1H, s) mp: 246.0-248.0; 197 Ή NMR ( CDCI3) δ 4.24 (6H, s), 6.98 (2H, s), 8.42 (2H, s). 198 Ή NMR (CDCI3) δ 4.22 (3H, s), 6.38 (1H, s), 6.92 (2H, d, J=8.8Hz), 6.98 (1H, s), 7.56 (2H , d, J=8.8Hz), 7.86 (1H, s). 199 NMR (CDCIj) δ 4.00 (3H, s), 4.08 (3H, s), 6.81 (1H, s), 7.08 (1H, s) , 7.62 (2H, t, 7.75 (1H, t, u/= 7.8 Hz), 8.13 (2H, d, l/= 7.8 Hz), 9.14 (1H, br-s). 200 Ή NMR (CDCI3) δ 2.71 (6H, s), 4.22 (3H, s), 6.72 (1H, br-s). 201 1H NMR (CDCI3) δ 3.72 (3H, s), 6.65 (1H, s), 7.08-7.71 (15H, m 202 Ή NMR (CDCIj) δ 2.05 (3H, s), 2.57 (3H, s), 3.84 (3H, s), 6.86 (1H, s), 7.01-7.03 (2H, m), 7.39-7.40 ( 3H, m) 203 Ή NMR (CDCI3) S 1.33 (3H, t, J=7.3Hz), 4.23 (3H, s), 4.26 (2H, q, J=7.3Hz), 6.26 (1H. dd, J= 2.5, 4.0 Hz), 7.00 (1H, dd, J=1.5, 4.0 Hz). 7.05 (1H. s), 7.18 (1Hr dd, J = 1.5, 2.5Hz), 9.60 (1H, br-s). 38 200916444 [Table 19]

化合物編號 物性値 204 Ή NMR (CDCI3) 6 4.22 (3H, s), 6.66 (1H, br^TeaTTTirT~~---- s), 7.06 (1H, d. J=7.8Hz), 7.12 (1Hf t. ^/=7.8^), 7.8B Πμ ' ' 〇H&gt; 205 fH NMR (CDGI3) 4.22 (3H, s), 6.21 (1H, -- 6.99 (2H, m), 7.31 (1H, d, J=8.3Hz), 7.93 (1H, br-s). 1 Z)t 6*97' 206 Ή NMR (CDCI3) δ 4.15 (3H, s), 4.82 (2H. -- =7.3HZ), 7.41-7.46 s)' 6·^ (1H. S), 7.04 (1H, d, ^ 207 Ή NMR (CDCI3, PPm): 1.45 (2H, m),】.75 (1H, s), 6.85 (1H, br-s) WH, s)· 6 75 m.p.: 195.2-196.4°CCompound No. 値204 Ή NMR (CDCI3) 6 4.22 (3H, s), 6.66 (1H, br^TeaTTTirT~~---- s), 7.06 (1H, d. J=7.8Hz), 7.12 (1Hf t ^/=7.8^), 7.8B Πμ ' ' 〇H&gt; 205 fH NMR (CDGI3) 4.22 (3H, s), 6.21 (1H, -- 6.99 (2H, m), 7.31 (1H, d, J= 8.3Hz), 7.93 (1H, br-s). 1 Z)t 6*97' 206 Ή NMR (CDCI3) δ 4.15 (3H, s), 4.82 (2H. -- =7.3HZ), 7.41-7.46 s ) 6·^ (1H. S), 7.04 (1H, d, ^ 207 Ή NMR (CDCI3, PPm): 1.45 (2H, m),].75 (1H, s), 6.85 (1H, br-s ) WH, s)· 6 75 mp: 195.2-196.4°C

[製劑例及試驗例] 以下例示本發明之製劑例及殺菌活性試驗例。於以 「份」表示「重量份」。 、 ^ (製劑例1) &lt;粒劑&gt; 100份 將30份化合物編號57之化合物、22份膨潤土、π份滑石、 3份Sorpol 5060(界面活性劑;日本東邦化學股份公司製 及少量消泡劑均诚捏’以籃式造粒機製成粒狀並乾燥後得粒劑 (製劑例2) &lt;粒劑&gt; 將15份化合物編號73之化合物、60份膨潤土、21份滑石、 1份十二烷基苯磺酸鈉、1份聚氧乙烯烷芳基醚及2份木質磺酸鈉 混合後,加適量之水均句揉捏,以籃式造粒機製成粒狀並乾燥後 得粒劑10ϋ份。 (製劑例3) &lt;可濕性粉劑&gt; 將50彳7?化合物編5虎143之化合物、40份碳酸妈、5份s〇;rp〇l 5039(陰離子性界面活性劑與白炭黑之混合物;日本東邦化學股份 公司^5商σ口名)及5伤白厌黑均匀混合並粉碎得可濕性粉劑。 (製劑例4) &lt;可濕性粉劑&gt; 39 200916444 將30份化合物編號194之化合物、63份高屬土、5份Sorpol 5039(陰離子性界面活性劑與白炭黑之混合物;日本東邦化學股份 公司製商品名)及2份白炭黑均匀混合並粉碎得可濕性粉劑。 (製劑例5) &lt;乳劑&gt; 將20份化合物編號3之化合物、55份二甲苯、2〇份二甲基 甲醯胺、5份Sorpol 2680(界面活性劑;日本東邦化學股份公司 製商品名)均匀混合得乳劑。 (製劑例6) &lt;水懸劑&gt; 將5份Sorpol 3353(非離子性界面活性劑;日本東邦化學股 份公司製商品名)、5份三仙膠之1%水溶液、4〇份水、1〇份乙二 醇混合均句,再加40份化合物編號23之化合物並攪拌後,用砂 磨機進行濕式粉碎,得水懸浮劑。 (製劑例7) &lt;粉劑&gt; 將5份化合物編號70之化合物、95份枯土均句混合得粉劑。 (試驗例1) &lt;水稻稻熱病防治效果試驗(撒佈試驗)&gt; 將依照製劑例4調製成本發明之化合物濃度為25〇ppm之可濕 性粉劑之稀釋液撒佈在水稻秧苗盆(品種:越光;2葉期)上並^ ΐ、。將此秧苗盆放入人工氣象室(設定條件:22。〇、12小時明暗循 環),以稻熱病菌之孢子懸浮液進行噴霧接種。其次,人工氣象室 保持高濕度狀態,於接種經7日後調查秧苗之病斑數。依下式計 算防治率。 ° 防治率(%) = (1 —處理區病斑數/無處理對照區病斑數)χ 1〇〇 結果有以下之化合物表現80以上防治率。 化合物編號:8、57、107、109、11〇、15〇、151、152、182、 189、204、205 另一方面,以下列比較化合物(日本專利特開平2 — 129171號 公報記載、下列結構式)進行相同試驗結果,防治率未達8〇。 200916444[Formulation Example and Test Example] The formulation examples and the bactericidal activity test examples of the present invention are exemplified below. By "parts" means "parts by weight". ^ (Formulation Example 1) &lt;granules&gt; 100 parts of 30 parts of compound No. 57, 22 parts of bentonite, π parts of talc, 3 parts of Sorpol 5060 (surfactant; manufactured by Toho Chemical Co., Ltd. and a small amount The foaming agent is kneaded in a granular shape by a basket granulator and dried to obtain a granule (Formulation Example 2) &lt;granules&gt; 15 parts of compound No. 73, 60 parts of bentonite, 21 parts of talc, After mixing 1 part of sodium dodecylbenzene sulfonate, 1 part of polyoxyethylene alkyl aryl ether and 2 parts of sodium lignin sulfonate, add appropriate amount of water and knead it, and make it into a granule by a basket granulator. After drying, 10 parts of granules were obtained. (Formulation Example 3) &lt;Wettable powder&gt; 50 彳7? compound was compounded with 5 143 compounds, 40 parts of carbonic acid mother, 5 parts s〇; rp〇l 5039 (anion a mixture of a surfactant and a white carbon black; a Japanese Pharmacy Co., Ltd., a 5 quot; σ mouth name) and a 5-white anaesthetic black uniformly mixed and pulverized to obtain a wettable powder. (Formulation Example 4) &lt;Wet WP &gt; 39 200916444 30 parts of compound number 194, 63 parts of high genus, 5 parts of Sorpol 5039 (anionic surfactant and white carbon black mixed (Compound product made by Japan Toho Chemical Co., Ltd.) and 2 parts of white carbon black are uniformly mixed and pulverized to obtain a wettable powder. (Formulation Example 5) &lt;Emulsion&gt; 20 parts of compound No. 3, 55 parts of two Toluene, 2 parts of dimethylformamide, 5 parts of Sorpol 2680 (surfactant; trade name of Toyo Chemical Co., Ltd., Japan) were uniformly mixed to obtain an emulsion. (Formulation Example 6) &lt;Aqueous suspension&gt; Sorpol 3353 (non-ionic surfactant; trade name manufactured by Toho Chemical Co., Ltd.), 5 parts of 1% aqueous solution of Sanxianjiao, 4 parts of water, 1 part of ethylene glycol, and 40 parts of compound The compound of No. 23 was stirred and then wet-pulverized by a sand mill to obtain an aqueous suspension. (Formulation Example 7) &lt;Powder&gt; 5 parts of the compound of Compound No. 70 and 95 parts of dry soil were mixed to obtain a powder. (Test Example 1) &lt;Rice rice fever control effect test (spray test)&gt; A dilution of a wettable powder having a compound concentration of 25 〇ppm prepared according to Formulation Example 4 was sprinkled on rice seedling pots. (Variety: Koshihikari; 2 leaf stage) and ^ ΐ, this seedling Put into the artificial meteorological room (setting conditions: 22. 〇, 12 hours light and dark cycle), spray inoculation with the spore suspension of rice fever bacteria. Secondly, the artificial meteorological room maintains a high humidity state, and investigates the disease of the seedling after 7 days of vaccination. The number of plaques was calculated according to the following formula: ° Control rate (%) = (1 - number of lesions in the treatment area / number of lesions in the untreated control area) χ 1 〇〇 results showed that the following compounds showed a rate of 80 or more. Compound Nos.: 8, 57, 107, 109, 11 〇, 15 〇, 151, 152, 182, 189, 204, 205 On the other hand, the following comparative compounds are described in the following Japanese Patent Publication No. Hei 2-129171, the following structure The same test results were carried out, and the control rate was less than 8〇. 200916444

上述結構與本發The above structure and the hair

光;3葉期)進行灌注處理。於灌注處理經3週後、, ί盆1品種:越 以稻熱病菌之 匕子芯洋液進行噴霧接種,在溫度25〇c、高濕度條件下放置丨週, 再調查病斑數。依下式計算防治率。 防治率(%) = (1 —處理區病斑數/無處理對照區病斑數)χ 100 結果有以下之化合物表現8〇以上防治率。 化合物編號:2、3、4、7、8、9、10、〗1、22、23、57、58、 6卜 68、69、70、73、82、83、93、94'96、103、106、107、1〇8、 111、112、122、127、142、143、145、146、150、151、154、160、 182、188、189、190、19卜 192、193、194、195、196、200、201、 202、203、204、205、206、207 另一方面,以下列比較化合物(日本專利特開平2- 129171號 公報記載、下列結構式)進行相同試驗結果,防治率未達50。Light; 3 leaf stage) perfusion treatment. After 3 weeks of perfusion treatment, the cultivar 1 was spray-inoculated with rice scorpion core liquid of rice blast fungus, and placed at the temperature of 25 ° C under high humidity conditions, and the number of lesions was investigated. The control rate was calculated according to the following formula. Control rate (%) = (1 - number of lesions in the treatment area / number of lesions in the untreated control area) χ 100 Results The following compounds showed a rate of prevention of more than 8〇. Compound Nos.: 2, 3, 4, 7, 8, 9, 10, 〖1, 22, 23, 57, 58, 6b 68, 69, 70, 73, 82, 83, 93, 94'96, 103, 106, 107, 1, 8, 111, 112, 122, 127, 142, 143, 145, 146, 150, 151, 154, 160, 182, 188, 189, 190, 19, 192, 193, 194, 195, 196, 200, 201, 202, 203, 204, 205, 206, 207 On the other hand, the same test results were carried out with the following comparative compounds (described in Japanese Patent Laid-Open No. Hei 2-129171, the following structural formula), and the control rate was not reached. 50.

CF NC 41 200916444 · 上述結構與本翻之化合㈣同處 中A為二齡夺,R6及R7之-方為氫原子另-方;芳V又式〇) (晶=3)〈水稻稻熱病防治效果試驗(育苗箱試驗)&gt; no將=照1劑(列1調製成之粒劑,以每箱50g處理水稻育苗r 3日後’移植於_分之i公故瓦格納妹在 以稻熱病菌之孢子懸浮液進行噴霧接種 同濕度條件下放置1週,再調查病斑數。依下式計 X 100 防治率⑻= (1-處理區病斑數/無處理對照區病斑數) 結果有以下之化合物表現8〇以上防治率。 化合物編號:3、23、57、73、ία、194 又,以下之化合物表現50以上、未達8〇之 化合物編號:7 + (試驗例4) &lt;番茄晚疫病防治效果試驗&gt; 1溶解於_之化合物以水稀釋成25Qppm, 在複葉展開4葉之番恭苗(品種:世界一 .母盆1〇mL撒佈 種1支)。風乾後移入18U_12小時日^盾= 病菌(Phytophthora infestans)之遊走孢子懸番0f= 種。接種經4日後調查小葉4片之發病進仃噴務接 治率。 $ 率,並依下式計算防 =%) = (1—處理區發病面積率/無處理對照區發病面積率) 結果有以下之化合物表現80以上防治率。 化合物編號:204 口 &gt; (試驗例5)&lt;菜豆灰黴病防治效果試驗(撒佈試驗、 42 200916444 將依照製劑例4調製 性;象稀釋液以每4盆5〇此撒=^ j 之可濕 子葉展開期)。待怖狂盆(ασ種.Green top ; 調製之分生孢子懸浮液(二5’上培養之灰黴病菌 、_娜以上=室2??種=種在子 後週一菜丑苗病贿,並依下式計算防治率。 4 7日 防治稍)= G —處理區病斑數/無處理對照區病斑數)χ 1〇〇 結果有以下之化合物表現80以上防治率。 化合物編號:150、205 表現害本發明之吼讀酸衍生物之殺菌劑 、又’本發明之化合物較日本專利特開平2 — 載之化合物表現更優異之效果。 5虎公報記 【圖式簡單說明】 無 【主要元件符號說明】 無 43CF NC 41 200916444 · The above structure and the combination of the above (4) in the same place A is two-year-old, R6 and R7--the hydrogen atom is another - Fang V is a formula 〇) (crystal = 3) < rice rice fever Control effect test (nursing box test) &gt; no will = 1 dose (column 1 prepared into granules, treated with 50g per box of rice seedlings r 3 days later 'transplanted in _ points i public Wagner sisters in rice heat The spore suspension of the pathogen was sprayed and inoculated under the same humidity condition for 1 week, and then the number of lesions was investigated. The X 100 control rate was determined according to the following formula (8) = (1 - number of lesions in the treatment area / number of lesions in the untreated control area) The following compounds exhibited a control rate of 8 〇 or more. Compound No.: 3, 23, 57, 73, ία, 194 Further, the following compounds showed a compound number of 50 or more and less than 8〇: 7 + (Test Example 4) &lt;; tomato late blight control effect test> 1 dissolved in _ compound diluted with water to 25Qppm, in the compound leaves to develop 4 leaves of the Gong seedlings (variety: world one. mother pot 1 〇 mL sprinkle 1). After air drying Move into 18U_12 hours day ^ shield = Phytophthora infestans, travel spore suspension 0f = species. Inoculation after 4 days investigation The incidence of 4 tablets of lobular sputum was in the rate of treatment. The rate was calculated according to the following formula: =1) = (1 - area of diseased area of treatment area / area of diseased area without treatment) The results showed the following compounds 80 The above prevention rate. Compound No.: 204 mouth &gt; (Test Example 5) &lt;Bean bean gray mold control effect test (spray test, 42 200916444 will be prepared according to Formulation Example 4; like dilution solution, 5 〇 every 4 pots = ^ j Wet cotyledon expansion period). To be horrible (ασ种.Green top; prepared conidia suspension (two 5' on the cultivation of Botrytis cinerea, _ Na above = room 2?? species = species in the post-subsidiary ugly disease, bribery, The control rate was calculated according to the following formula: 4 7 days of prevention and control = G - number of lesions in the treatment area / number of lesions in the untreated control area) χ 1〇〇 The following compounds showed a rate of 80 or more. Compound No.: 150, 205 A compound which exhibits a bactericidal agent which is harmful to the acid derivative of the present invention, and which is more excellent in the compound of the present invention than the compound of Japanese Patent Laid-Open No. 2-. 5 Tiger Bulletin [Simplified illustration] None [Main component symbol description] None 43

Claims (1)

200916444 七、申請專利範圍:200916444 VII. Patent application scope: 1·-種吨唾叛酸衍生物,以下列一般式⑴表 R2 R3 一般式(1 ) 表示氫原子或碳原子數1〜6之烧基; 1 ,自獨立,表示氫原子、碳原子數1〜6之烷基、碳原 夕占二二齒化山烧基、碳原子數1〜6之烧氧基、碳原子數卜6 基、碳原子數1〜6找硫基、碳原子數卜6之鹵化 子數1〜6之燒亞雜基、碳原子數1〜6之齒化烧 石^其%^原子數1〜6之烧雜基、碳原子數1〜6之函化烧 '表不一0R4、一 SR5、— NRY、或—NR8Nr9r10. J- - 3;^.-. 原子數1〜6之炫基、可被取; R5表示碳原子數1〜12之燒基、碳原 ^數2〜6之烯基 '碳原子數3〜6之環S 3碳6 ^美可之雜芳基取代之碳原子數1〜6之燒基、可被取代 之方基、或可被取代之雜芳基; 攸取代 R7如表示碳原子數5〜12之烷基、碳原子數2〜 山 原子數3〜6之環烯基、碳原子數2〜6之块其 ^ 土、:反 原子數1〜6之絲、或被碳原子數卜6之^ 代^ 子數1〜6之烧基時,R6表示氳原子、碳原 犬土取代之石屄原 原子數2〜6之縣、碳軒數3〜6之環聰、初^^ 44 200916444 炔基、可被取代之雜芳基、醯基 基、芳石黃酿基、烷胺絲、或芳胺縣.土年級土、烧石黃醯 又’ R7如表示碳原子數3〜6之環'^基、可被取代之 氧幾基、“、心二:取 山R、R及R1D各自獨立’表示氫原子、碳原子數丨〜12之烷芙、 Ϊ〜碳原子數2〜6之稀基、碳原子數二6 代之綠、可被取代之雜芳基,基、 基人,、烧石黃酿基、芳石黃酿基、烧胺幾基、或芳胺 緣基;但’9不含f、R9及R1。均為氫原子之情形; 又’ R及R1Q可互相鍵結形成碳原子數2〜5之雜環 A上如,專利範圍第1項記載之吼錢酸衍生物,其中,-般式(1)之R表不碳原子數丨〜6之鹵化烷基。 其中,一 〜6之氟烷 其中,一 丄如申請專利範圍第2項記載之t坐叛酸衍生物, Ϊ 原子數1〜6之絲,R2為碳原子數1 4·如申請專利難第3項記載之㈣鏡衍生物, 般式(1)之 A 為一NR6R7 或—NHNR9R10。 5· -種t續酸衍生物之製造方法,雜造φ請專利範圍第ι 〜4項任-項記載之〇比錢酸衍生物,包含使下列一般式⑵表示 之化合物與下列-般式⑶絲之化合物進行反應之製程:1·-species tons of salicylic acid derivatives, in the following general formula (1), R2 R3, general formula (1) represents a hydrogen atom or a carbon atom having 1 to 6 carbon atoms; 1 , self-independent, indicating a hydrogen atom, a carbon atom 1 to 6 alkyl group, carbon atomic octagonal dentate base, alkoxy group having 1 to 6 carbon atoms, carbon atom number 6 group, carbon number 1 to 6 to find sulfur group, carbon number The pyridyl group having 1 to 6 halogenated groups, the toothed calcined carbon having 1 to 6 carbon atoms, the % of the halogenated group having 1 to 6 atomic number, and the number of carbon atoms 1 to 6 'Table is not 0R4, a SR5, - NRY, or -NR8Nr9r10. J- - 3; ^.-. Atomic number 1~6 of the dazzle, can be taken; R5 represents a carbon number of 1~12, a carbon atom having 2 to 6 alkenyl groups having a carbon number of 3 to 6 ring S 3 carbon 6 ^ a heteroaryl group substituted with a carbon atom having 1 to 6 carbon atoms, a square group which may be substituted, or a heteroaryl group which may be substituted; a hydrazine-substituted R7 such as an alkyl group having 5 to 12 carbon atoms; a cycloalkenyl group having 2 to 6 carbon atoms; and a carbon number of 2 to 6; ,: the number of anti-atoms of 1 to 6, or the number of carbon atoms, the number of 2, the number of 1 to 6 At the base time, R6 represents a cesium atom, a carbon atom, a terrestrial earth replaced by a scorpion atomic number of 2 to 6 counties, a carbon number of 3 to 6 ring Cong, a first ^^ 44 200916444 alkynyl group, a substituted heteroaryl group , fluorenyl base, aryl stone yellow base, alkyl amine silk, or aromatic amine county. Earth grade soil, burnt stone xanthine and 'R7, such as ring number of carbon atoms 3~6, can be replaced by oxygen A few bases, ", heart two: take the mountains R, R and R1D each independently' means a hydrogen atom, a number of carbon atoms 丨 ~ 12 alkane, Ϊ ~ carbon number 2 ~ 6 of the rare base, carbon number two 6 generations Green, heteroaryl which can be substituted, base, basal, pyrotechnic, aryl yellow, amine, or aryl amine; but '9 does not contain f, R9 and R1 In the case of hydrogen atoms; and 'R and R1Q can be bonded to each other to form a heterocyclic ring A having a carbon number of 2 to 5, as described in the patent field, the derivative of the baric acid, wherein - 1) R represents a halogenated alkyl group having a carbon number of 丨~6. Among them, a fluorocarbon of one to six, wherein, as described in the second paragraph of the patent application, the t-reactive acid derivative, Ϊ atomic number 1~ 6 filament, R2 is carbon No. 1 4 · If the patent application is difficult to record the fourth (4) mirror derivative, the general formula (1) A is a NR6R7 or -NHNR9R10. 5 · - a method for the manufacture of a t-reductive acid derivative The oxime-based acid derivative described in the above paragraphs 1-4 to 4 includes a process for reacting a compound represented by the following general formula (2) with a compound of the following formula (3): •般式(2) 45 200916444 ^ [式/二^表/歲山原子或碳原子數卜6之貌基;只2及尺3各自 獨立,表不虱原子、碳原子數!〜6之燒基 化炫基、碳原子數i〜6之炫氧基、碳 K 數卜6之统亞顧基、〜硫基、碳原子 原子數1〜6之⑽嫩細基、«原 方表示碳原子數1〜6之齒化 Α 一Η 一般式(3 [式中,Α 表示一OR4、—SR5、—NR6r7、或—服8NRgRl0. 料之絲、碳原子數3〜6之環燒基、碳 =數2〜6之絲、碳原子數3〜6之環烯基、碳原子數卜6之 、之:其可方基取代之碳原子數1〜6之烷基、可被取代 之方基、或可被取代之雜芳基; 厂示碳ϋ數1〜12找基、碳肝數3〜6之環烧基、碳 数i〜u心岬基、碳原子數3〜6之環烯基、碳原子數9〜fi夕 炔^、可被取代之雜芳基取代之碳原子數丨〜6之烷基、可被取代 之方基、或可被取代之雜芳基; f如表示碳原子數5〜12之烷基、破原子數2〜6之烯基、碳 3〜6之環職、碳原子數2〜6之炔基、被縣取代之碳 ς =數1〜6之烧基、或被碳原子數卜6之烧氧麟取代之碳原 语完基時’ R6表示氫原子、碳原子數1〜12之烷基、碳 也數2〜6之烯基、碳原子數3〜6之環烯基、碳原子數2〜6之 装土、可被取代之雜芳基,基、烧氧、芳氧縣、烧雜 基、芳磺醯基、烷胺羰基、或芳胺羰基; 又,R7如表示碳原子數3〜6之環烷基、可被取代之芳基、 σ被取代之料基時’ 表示碳原子數2〜6之絲、碳原子數^ 46 200916444 〜6之婦基、碳原子數2〜6之炔基、可被取代之芳基、可被取 代之雜芳基、酿基、烧驗基、芳氧祕、辦醯基、芳確醯基、 烧胺幾基、或芳胺幾基; 山R8、R9及R115各自獨立,表示氫原子、碳原子數丨〜12之烧基、 石厌數3〜6之環垸基、碳原子數2〜β之烯基、碳原子數3〜6 之環烯基、碳原子數2〜6之炔基、可被取代之雜芳基取代之碳原 1〜6之烷基、可被取代之芳基、可被取代之雜芳基、醯基、 烷氧羰基、芳氧羰基、烷磺醯基、芳磺醯基、烷胺羰基、或芳胺 羰基;但,不含R8、R9&amp;Rh&gt;均為氫原子之情形; 又’ R9及R1()可互相鍵結形成碳原子數2〜5之雜環基]。 6.—種吡唑羧酸衍生物之製造方法,係製造申請專利範圍第i 〜4項任一項記載之吡唑羧酸衍生物,包含使下列一般式⑷表示 之化合物與下列一般式表示之化合物進行反應之製程:• General (2) 45 200916444 ^ [Formula / two ^ table / age mountain atom or carbon number number of 6 appearance base; only 2 and ruler 3 are independent, the table does not 虱 atom, carbon number! ~6 of the alkyl group, the number of carbon atoms i ~ 6 of the oxy group, carbon K number of 6 of the Azul base, ~ sulfur, carbon atom number of 1 ~ 6 (10) tender fine base, «original The square indicates a tooth having a carbon number of 1 to 6 Α a general formula (3 [wherein, Α represents an OR4, -SR5, -NR6r7, or - 8NRgRl0. A wire of a material, a ring of 3 to 6 carbon atoms) a base group, carbon = 2 to 6 filaments, a cycloalkenyl group having 3 to 6 carbon atoms, and a carbon number of 6; the alkyl group having 1 to 6 carbon atoms which may be substituted by a aryl group may be a substituted square group or a heteroaryl group which may be substituted; a carbonic acid number of 1 to 12, a carbonic acid number of 3 to 6 ring-burning group, a carbon number i~u heart group, and a carbon number of 3~ a cycloalkenyl group of 6 or a heteroaryl group having a carbon number of 9 to fi acetylene, a heteroaryl group substituted with a heteroaryl group substituted with a carbon number of 丨~6, a subgroup which may be substituted, or a substitutable group which may be substituted f represents an alkyl group having 5 to 12 carbon atoms, an alkenyl group having 2 to 6 atomic atoms, a ring having 3 to 6 carbon atoms, an alkynyl group having 2 to 6 carbon atoms, and a carbon ς substituted by a county. The carbon base of 1 to 6 or the carbon primitive replaced by the carbon atom of the carbon number When R 6 represents a hydrogen atom, an alkyl group having 1 to 12 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, a cycloalkenyl group having 3 to 6 carbon atoms, or a filler having 2 to 6 carbon atoms, a substituted heteroaryl group, a group, a calcined oxygen, an aryloxy group, a pyrrolyl group, an arylsulfonyl group, an alkylamine carbonyl group, or an arylamine carbonyl group; further, R7 represents a cycloalkyl group having 3 to 6 carbon atoms; When the substituted aryl group and the σ-substituted material group are ', the filament representing a carbon number of 2 to 6 and the number of carbon atoms ^ 46 200916444 ~6, the alkynyl group having 2 to 6 carbon atoms, may be substituted An aryl group, a heteroaryl group which may be substituted, a brewing group, a pyridyl group, an aryloxy group, an anthracene group, an aromatic sulfhydryl group, an acridine group, or an arylamine group; the mountains R8, R9 and R115 are each independently , a hydrogen atom, a carbon atom having a number of 丨~12, a ring thiol group having a stone number of 3 to 6, an alkenyl group having 2 to β carbon atoms, a cycloalkenyl group having 3 to 6 carbon atoms, and a carbon number 2 to 6 alkynyl, substituted heteroaryl substituted carbonogen 1 to 6 alkyl, substituted aryl, substituted heteroaryl, fluorenyl, alkoxycarbonyl, aryloxycarbonyl , alkanesulfonyl, arylsulfonate , an alkylamine carbonyl group, or an arylamine carbonyl group; however, the case where R8, R9&Rh&gt; are all hydrogen atoms; and 'R9 and R1() may be bonded to each other to form a heterocyclic group having 2 to 5 carbon atoms] 6. A method for producing a pyrazole carboxylic acid derivative, which comprises producing a pyrazolecarboxylic acid derivative according to any one of the above items (i) to 4, comprising a compound represented by the following general formula (4) and the following general formula: The process of reacting the indicated compound: [式中,R1表示氫原子或碳原子數i〜6之烷基;圮及p各自 獨立,表示氫原子、碳原子數丨〜6之烷基、碳原子數丨〜6之鹵 化烷基、碳原子數1〜6之烷氧基、碳原子數丨〜6之_化烷氧基、 碳原子數1〜6之烷硫基、碳原子數丨〜6之齒化烷硫基、碳原子 數1〜6之烷亞磺醯基、碳原子數丨〜6之齒化烷亞磺醯基、碳原 子數1〜6之烧磺醯基、碳原子數1〜6之鹵化烧磺醯基、鹵素原 子、氰基或硝基;但R2及R3之至少—方為碳原子數i〜6之鹵化烷 基;又,Y表不脫去基]。Wherein R1 represents a hydrogen atom or an alkyl group having a carbon number of i to 6; and hydrazine and p are each independently represented by a hydrogen atom, an alkyl group having a carbon number of 丨6, and a halogenated alkyl group having a carbon number of 丨6. An alkoxy group having 1 to 6 carbon atoms, an alkoxy group having a carbon number of 丨~6, an alkylthio group having 1 to 6 carbon atoms, a toothed alkylthio group having a carbon number of 丨6, and a carbon atom a sulfinyl group having 1 to 6 alkyl groups, a sulfinyl group having 1 to 6 carbon atoms, a sulfonyl group having 1 to 6 carbon atoms, and a halogenated sulfonyl group having 1 to 6 carbon atoms And a halogen atom, a cyano group or a nitro group; but at least one of R2 and R3 is a halogenated alkyl group having a carbon number of i to 6; further, Y is not a leaving group. 一般式(3) 47 200916444 [式中 ’ A 表示一〇R4、__ QD5 β 7 R4#干石卢原名叙9 SR、—顺R、或一NR8膽9R10; R表不灰原子數3〜12之炫基 , 原子數2〜6之稀基、端片不批Q c謂于數3〜6之诚基、碳 6 mi l 语工it”子數5〜12之絲、碳原子數2〜6之婦美、石山 肩子數1 e ·Γ^子數2〜6之絲、被絲取^&quot;之碳&lt; «Ι^Βΐίίί' W mm _子' 碳原子數1〜12之烧基、碳 5數2〜6之烯基、碳原子數3〜6之環烯基、碟原子數2〜6 ‘ 、、土、可被取代之雜芳基、醯基、烷氧羰基、芳氧羰基、 基、芳磺醯基、烷胺羰基、或芳胺羰基; 只-1 、又,R7如表示碳原子數3〜6之環烷基、可被取代之 可被取代之雜芳基時’ R6表示碳原子數2〜6之烯基、碳原容3 :6之環婦基、碳原子數2〜6之姨基 '可被取代之芳基、可⑽ 代之雜芳基、醯基、燒驗基、芳氧減、_醯基、芳 ^ 烷胺羰基、或芳胺羰基; /、- 土、 山R8、R9及Γ各自獨立,表示氫原子、碳原子數丨〜12之烷 石厌原子數3〜6之環烧基、碳原子數2〜6之稀基、碳原子數3〜 之環烯基、碳原子數2〜6之炔基、可被取代之雜芳基取代之硬月 子,1〜6之烷基、可被取代之芳基、可被取代之雜芳基、醯义'、 烷氧羰基、芳氧羰基、烷磺醯基、芳磺醯基、烷胺羰基、·&quot;、 m基;但,不含r8、R9及r均為氫原子之情形; 一女 又’ R9及Γ可互相鍵結形成碳原子數2〜5之雜環基;|。 7.—種殺菌劑’含有申請專利範圍第1〜4項任—項記戴之。 唾羧酸衍生物之至少1種當做有效成分。 比 48 200916444 8.如申請專利範圍第7項記載之殺菌劑,其特徵為農園藝用殺 菌劑。 49 200916444 四、指定代表圖: ' (一)本案指定代表圖為:無圖式。 (二)本代表圖之元件符號簡單說明: 益 五、本案若有化學式時,請揭示最能顯示發明特徵的化學式: κ~ KGeneral formula (3) 47 200916444 [In the formula, A represents a 〇R4, __ QD5 β 7 R4# dry stone ru is the original name 9 SR, - cis R, or a NR8 biliary 9R10; R table does not ash atom number 3~12 The sleek base, the atomic number 2~6 of the thin base, the end piece is not approved Q c is the number 3~6 of the base, the carbon 6 mi l the semantics it" the number of 5~12 filament, the carbon number 2~ 6 Women's Beauty, Stone Mountain Shoulder Number 1 e ·Γ^子子2~6丝丝, 被取取^&quot;的碳&lt;«Ι^Βΐίίί' W mm _子' Carbon number 1~12 a base, a carbon number of 2 to 6 alkenyl groups, a cyclopentene group having 3 to 6 carbon atoms, a disc atomic number of 2 to 6 ', a soil, a heteroaryl group which may be substituted, a mercapto group, an alkoxycarbonyl group, and an aromatic group. An oxycarbonyl group, a aryl sulfonyl group, an alkylamine carbonyl group, or an arylamine carbonyl group; only -1 and, further, R7 represents a cycloalkyl group having 3 to 6 carbon atoms, and a heteroaryl group which may be substituted When R 6 represents an alkenyl group having 2 to 6 carbon atoms, a carbon group having a carbon content of 3:6, a fluorenyl group having 2 to 6 carbon atoms, an aryl group which may be substituted, a heteroaryl group which may be substituted with (10), Sulfhydryl, pyridine, aryloxy, hydrazino, arylalkylamine carbonyl, or arylamine carbonyl; /, - , R8, R9 and yttrium are each independently, and represent a hydrogen atom, a carbon atom number of 丨~12, an alkylene group having an anatomical number of 3 to 6, a ring-burning group having 2 to 6 carbon atoms, and a carbon number of 3 to 6. a cycloalkenyl group, an alkynyl group having 2 to 6 carbon atoms, a hard group substituted with a heteroaryl group which may be substituted, an alkyl group of 1 to 6, an aryl group which may be substituted, a heteroaryl group which may be substituted, and an anthracene义', alkoxycarbonyl, aryloxycarbonyl, alkanesulfonyl, arylsulfonyl, alkylamine carbonyl, ·&quot;, m-based; however, without r8, R9 and r are hydrogen atoms; Further, 'R9 and hydrazine can be bonded to each other to form a heterocyclic group having 2 to 5 carbon atoms;| 7. 7. A fungicide' contains the scope of the patent application No. 1 to 4, which is the item of the product. At least one of the substances is used as an active ingredient. Compared with 48 200916444 8. The bactericide described in claim 7 is characterized by a bactericidal agent for agriculture and horticulture. 49 200916444 IV. Designated representative figure: '(1) Representative of the case Pictured: No picture. (2) Simple description of the symbol of the representative figure: Yiwu. If there is a chemical formula in this case, please reveal the best display invention. Characterized by the chemical formula: κ ~ K
TW097129688A 2007-08-29 2008-08-05 Pyrazole carboxylic acid derivative, method of producing same and fungicide TW200916444A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007222384 2007-08-29

Publications (1)

Publication Number Publication Date
TW200916444A true TW200916444A (en) 2009-04-16

Family

ID=40387009

Family Applications (1)

Application Number Title Priority Date Filing Date
TW097129688A TW200916444A (en) 2007-08-29 2008-08-05 Pyrazole carboxylic acid derivative, method of producing same and fungicide

Country Status (5)

Country Link
JP (2) JPWO2009028280A1 (en)
AR (1) AR068115A1 (en)
CL (1) CL2008002554A1 (en)
TW (1) TW200916444A (en)
WO (1) WO2009028280A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2253617A1 (en) 2009-05-20 2010-11-24 Bayer CropScience AG Halogenated compounds as pesticides
US8987470B2 (en) 2010-10-27 2015-03-24 Solvay Sa Process for the preparation of pyrazole-4-carboxamides
MY169319A (en) * 2011-07-26 2019-03-21 Sanofi Sa 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
CN112244015B (en) 2012-02-29 2022-05-17 株式会社Mmag Pest control composition comprising novel iminopyridine derivatives
JP6243918B2 (en) 2012-10-16 2017-12-06 トレロ ファーマシューティカルズ, インコーポレイテッド PKM2 modulators and methods for their use
JP6213266B2 (en) * 2013-01-30 2017-10-18 住友化学株式会社 Amide compounds and their use for controlling harmful arthropods
KR102161867B1 (en) * 2013-01-30 2020-10-05 스미또모 가가꾸 가부시끼가이샤 Method for controlling arthropod pest
CN104045634A (en) * 2014-06-06 2014-09-17 浙江工业大学 Pyrazolecarboxamide compound containing difluoromethyl as well as preparation method and application of pyrazolecarboxamide compound
CN105601618B (en) * 2016-01-11 2018-04-27 天津医科大学 Aromatic imides class compound and preparation method and application
JP2022527451A (en) * 2019-03-22 2022-06-02 スミトモ ダイニッポン ファーマ オンコロジー, インコーポレイテッド PKM2 Modulator and How to Use It
EP3941463A1 (en) 2019-03-22 2022-01-26 Sumitomo Dainippon Pharma Oncology, Inc. Compositions comprising pkm2 modulators and methods of treatment using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0253775A (en) * 1988-08-18 1990-02-22 Nissan Chem Ind Ltd Pyrazole carboxamide derivative and herbicide
JPH02129171A (en) * 1988-11-08 1990-05-17 Nissan Chem Ind Ltd Pyrazolecarboxanilide derivative and agent for controlling harmful life
JPH09176125A (en) * 1995-05-31 1997-07-08 Nissan Chem Ind Ltd 5-pyrazolecarboxylic acid amide derivative and plant blight controlling agent
JPH09176124A (en) * 1995-12-25 1997-07-08 Nissan Chem Ind Ltd Pyrazoline derivative and plant blight controlling agent
EP1384714A1 (en) * 2001-04-06 2004-01-28 Nihon Nohyaku Co., Ltd. Pyrazolecarboxamide derivative, intermediate therefor, and pest control agent containing the same as active ingredient

Also Published As

Publication number Publication date
JPWO2009028280A1 (en) 2010-11-25
WO2009028280A1 (en) 2009-03-05
AR068115A1 (en) 2009-11-04
CL2008002554A1 (en) 2009-01-16
JP2009073823A (en) 2009-04-09

Similar Documents

Publication Publication Date Title
TW200916444A (en) Pyrazole carboxylic acid derivative, method of producing same and fungicide
JP5034142B2 (en) Plant disease control composition
KR100842135B1 (en) Diamine derivative, process of preparation thereof, and fungicide comprising diamine derivative as an active ingredient
CN104520273B (en) 2-amino-nicotinic acid ester derivant and the biocide with it as effective ingredient
TW307668B (en)
TW200808789A (en) 1,2-benzisothiazole derivative, and agricultural or horticultural plant disease-controlling agent
JP3164762B2 (en) Substituted thiophene derivatives and fungicides for agricultural and horticultural use containing the same as active ingredients
TW479053B (en) Hydrazineoxoacetamide derivatives and pesticides
JP2009078991A (en) Thiophene carboxylic acid derivative and its manufacturing method, and bactericide
JPH10130268A (en) Substituted thiophene derivative and agricultural and horticultural fungicide comprising the same as active ingredient
JP2009073818A (en) Isoxazole carboxylic acid derivative and method for producing the same, and microbicide
TW294578B (en)
TW536387B (en) Pyrazolinone compound
JP2010083763A (en) Pyrazole derivative, method of producing the same, and bactericide
JP3982886B2 (en) Substituted thiophene derivatives and plant disease control agents comprising the same
ES2235771T3 (en) ARIL AND HETEROARIL-CICLOPROPIL-OXIMA-ETERES AND ITS USE AS FUNGICIDES AND INSECTICIDES.
JP3780541B2 (en) Plant disease control agent
TW199887B (en)
JPH09301974A (en) Substituted thiophene derivative and germicide for agriculture and horticulture containing the same as active ingredient
JP5360244B2 (en) Plant disease control composition
JP2010077090A (en) Isoxazole derivative and method for producing the same, and fungicide
JPH11335364A (en) New acid anilide derivative and plant disease damage comprising the same as active ingredient
TW513395B (en) Benzyloxy substituted aromatics and their use as fungicides
JP2001151770A (en) Substituted thiophene derivative and agricultural and horticultural fungicide comprising the same as active ingredient
JPH07309825A (en) Oxime ether derivative, its application and production intermediate therefor